Global Drug Addiction Treatment Market By Treatment Type (Detoxification, Medication (Naltrexone, Acamprosate, Disulfiram, Buprenorphine, Methadone, Others), Behavioral Therapies & Counseling (Cognitive-Behavioral Therapy (CBT), Motivational Enhancement Therapy (MET), Multidimensional Family Therapy, Dialectic Behavioural Therapy, Rational Emotive Behavior Therapy (REBT) Therapy, Therapeutic Communities, Recovery Housing, Self-help Groups, Online Counseling, Psychotherapy, Mindfulness, Specialty Therapies (Music Therapy, Yoga Therapy, Animal Assisted Therapy, Art Therapy, Others), Others), Substance Abuse Services (Vocational Services, Mental Health Services, Medical Services, Educational Services, HIV/AIDS Services, Legal Services, Family Services, Others), Combination Treatment Others); By Application (Withdrawal Symptoms, Relapse Prevention, Co-Occurring Conditions (Depression, Anxiety Disorders (Including Post-Traumatic Stress Disorder), Bipolar Disorder, Schizophrenia, Others), Others); By Age Group (Adolescents, Young Adults, Adults, Elderly); By Drug Type (Illicit Drugs (Cocaine, Crack Cocaine, Ecstasy, Marijuana, Hallucinogens, Methamphetamine, Heroin, Others), Opiates/Opioids, Sleeping Pills, Stimulants, Others); By Addiction Type (Mild Substance Use Disorders, Chronic Substance Use Disorders); By Providers (Hospitals/Clinics, Rehabilitation Centers, Urgent Care Centers, Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Industry Trends
Growing prevalence of drug consumption across continents has created a series of illness and even deaths of young adults and adults, thus, creating high demand for drug addiction treatment services to circumnavigate this health care issue.
Psychoactive substance use has become universal public-health problem which is caused due to a combination of factors including biological, social and others. United Nations World Drug Report 2020 stated that in 2018, more than 269 million people consumed drugs across the globe and this number has risen by 30% in past decade. The growing addiction of drugs is causing severe illnesses which affects the person’s basic abilities such as learning, judgment, decision-making, memory and behaviour. Along with health, it also has negative impacts on the economy of the nations. Drug addiction is a complex psychological disorder and overcoming this addiction takes more than good intentions or a strong will, thus, creating demand for a variety of medical treatments. These treatments are a combination of behavioural therapies and medications, intended to assist individuals to stop compulsive drug abuse. As drug addiction is a form of chronic psychological disorder, various treatments are offered at different stages of recovery which makes the entire treatment a long-term process. Increasing number of health care providers and rehabilitation centres including Castle Craig Hospital, McLean Hospital, OSF Healthcare System, Akron Children's Hospital and many others have started addiction treatment programs at their facilities. Thus, the rise in number of people facing substance abuse disorder is driving the demand in global drug addiction treatment market.
High costs associated with drug addiction therapies and treatment is causing resistance among people to opt for one or drop-out from the on-going treatment, thus, hindering the growth of global drug addiction treatment market. Government reforms to make health care affordable and available to every individual are effectively tackling this challenge. For instance, the Affordable Care Act (ACA) of the U.S includes substance use disorder treatments in essential health benefits being provided to Americans. It mandates health insurance providers to include drug addiction treatment services in their policies. Such initiatives are reducing the economic burden of treatments on individuals and many for-profit treatment providers are taking advantage of this opportunity thus, making a shift towards privatized care. These government reforms coupled with entry of new private players is anticipated to boost the growth of global drug addiction treatment market in future years.
Healthcare providers are innovating the conventional drug addiction treatments with incorporation of advanced medical devices to make the treatment more effective. Market players are investing in diagnostic-therapeutic devices, audio-visual brain stimulation devices, neuro jet therapy devices and others for increasing the efficiency and reducing fatalities and costs associated with treatments. For instance, in June 2020, Masimo announced a launch of medical device, NSS-2 Bridge, for reducing the symptoms associated with opioid withdrawal. This device is placed behind the ear and sends electrical pulses to stimulate certain brain nerves and reduce neuron activity. These innovative medical device based therapies are anticipated to propel the growth of global drug addiction treatment market over forecast years.
The social distancing measures undertaken amidst the recent outbreak of COVID-19 pandemic to contain the spread of infection are creating difficulties in the treatment of drug addicts. These crisis are posing a growth opportunity for telehealth services in drug addiction treatment. The Government of India’s national drug de-addiction helpline witnessed a huge spike in calls as the lockdown was imposed across nation. The total number of calls this helpline received from April to June was more than 9400 which is 200% more than before lockdown period. Owing to this rise in number of people opting for telehealth services, government agencies are legalizing these services. For instance, in March 2020, the U.S. Drug Enforcement Agency proposed relaxation in rules for permitting telehealth services in substance abuse programs. Thus, the rise of telehealth services amidst the COVID-19 pandemic is anticipated to drive the growth of global drug addiction treatment market.
Application Outlook:
The type of treatment depends on the patient’s individual needs and, often, on the types of drugs they use. Repeated harmful drug use causes changes in mental condition of a person that hampers the self-control and ability to resist intake of drugs. These changes are persistent which makes drug addiction a relapsing disease, thus increasing the risk of patients returning to drug use. National Institute on Drug Abuse stated that 40 to 60% of drug addict patients who are undergoing recovery treatment face relapse. This high risk of patients resuming drug use is contributing towards demand of relapse prevention treatments. Relapse prevention is effectively achieved through behavioural therapies. For instance, The Recovery Village, a drug rehabilitation centre, provides its patients with cognitive behavioural therapies to prevent and overcome relapse by assisting them to draft a relapse prevention plan and providing regular counselling. Thus, the high number of patients facing relapse is driving the share of relapse prevention application in global drug addiction treatment market.
Drug Type Outlook:
Based on type of drugs, illicit drugs contributed highest share in the global drug addiction treatment market in 2018. The high number of people consuming illicit drugs such as marijuana, heroin and others have contributed towards their high share. United Nations states that marijuana is the most widely used drug around the world with around 192 million users in 2018. The legalisation of this drug in some countries has further fuelled the number of addicts. However, there has been a considerable shift from heroine drug addicts to opioid drug addicts. The number of people consuming opioids or opiates especially fentanyl is witnessing an upsurge worldwide. World Health Organization stated that in 2019 number of opioid users recorded around the globe were 53 million, which was 56% more than the previous year. In similar instance, statistics revealed by the U.S Centers for Disease Control and Prevention in March 2019 stated that death rates involving synthetic opioids increased by 10%. The agency also highlighted that in 2018, opioid overdose resulted in deaths of 46,000 U.S citizens. This rise in harmful use of opioid/opiates is creating high demand for medical treatments, thus, fuelling their share in global drug addiction treatment market at highest rate.
Regional Outlook:
North America region registered the highest share in global drug addiction treatment market in 2018 with more than a tenth of global drug addicts in the region. However, Asia Pacific region is anticipated to witness high growth rate in global drug addiction treatment market in future years. The lack of awareness and scarcity of treatment facilities across the low and middle income countries of the region has contributed towards rise in harmful and dependent use of drugs. According to the recent Magnitude of Substance Abuse in India report, published by Indian government in 2019, there were more than 30 million drug users across India among which 20 million were dependent users. These growing number of harmful drug users are inflating the demand for de-addiction treatments. Hospitals and other medical facilities are eyeing this trend as an opportunity to increase their revenue generation and introducing new drug addiction treatment services. For instance, All India Institute of Medical Sciences (AIIMS) hospital launched a mobile drug addiction treatment facility in March 2019, which dispenses methadone for treatment of opioid addicts. Thus, the high demand from number of harmful drug users coupled with emergence of new players with novel treatments is anticipated to drive the share of Asia Pacific region in global drug addiction treatment market over the forecast period.
In terms of revenue, global drug addiction treatment market was valued at US$ 7109.16 Mn in 2018 and is anticipated to grow at a CAGR of 6.5% over the forecast period. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Drug Addiction Treatment Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of drug addiction treatment market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the drug addiction treatment market are Addiction Friend, AddictionCenter.com, Advanced Recovery Systems, Alkermes, American Addiction Centers, Inc., Asia Health Co., Ltd., BioCorRx, Inc., Castle Craig Hospital, Cedars at Cobble Hill, Detox of South Florida Inc., DyAnsys Inc., Foundations Wellness Center, Help 4 Addiction, Hope Recovery Services Limited, Indivior PLC, Novartis AG, Paracelsus Medical AG, Phoenix Programmes, Pinnacle Treatment Centers, Step 1 Recovery Centre, Summit BHC, The Augustine Recovery Center and Touchstone Ranch Recovery Center amongst others.
Global Drug Addiction Treatment Market:
By Treatment Type
- Detoxification
- Medication
- Naltrexone
- Acamprosate
- Disulfiram
- Buprenorphine
- Methadone
- Others
- Behavioral Therapies & Counseling
- Cognitive-Behavioral Therapy (CBT)
- Motivational Enhancement Therapy (MET)
- Multidimensional Family Therapy
- Dialectic Behavioural Therapy
- Rational Emotive Behavior Therapy (REBT) Therapy
- Therapeutic Communities
- Recovery Housing
- Self-help Groups
- Online Counseling
- Psychotherapy
- Mindfulness
- Specialty Therapies
- Music Therapy
- Yoga Therapy
- Animal Assisted Therapy
- Art Therapy
- Others
- Others
- Substance Abuse Services
- Vocational Services
- Mental Health Services
- Medical Services
- Educational Services
- HIV/AIDS Services
- Legal Services
- Family Services
- Others
- Combination Treatment
- Others
By Application
- Withdrawal Symptoms
- Relapse Prevention
- Co-Occurring Conditions
- Depression
- Anxiety Disorders (Including Post-Traumatic Stress Disorder)
- Bipolar Disorder
- Schizophrenia
- Others
- Others
By Age Group
- Adolescents
- Young Adults
- Adults
- Elderly
By Drug Type
- Illicit Drugs
- Cocaine
- Crack Cocaine
- Ecstasy
- Marijuana
- Hallucinogens
- Methamphetamine
- Heroin
- Others
- Opiates/Opioids
- Sleeping Pills
- Stimulants
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2013 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Drug Addiction Treatment Market
6. Market
Synopsis: Drug Addiction Treatment
Market
7. Drug
Addiction Treatment Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Drug Addiction Treatment Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Drug Addiction Treatment Market
7.6. Porter’s Five Force Analysis
7.7. Analysis
on Impact of Covid-19 on Global Drug Addiction Treatment Market
8. Global Drug
Addiction Treatment Market Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
Drug Addiction Treatment Market Revenue (US$ Mn)
8.2. Global
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Type
8.2.1. Detoxification
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2013 – 2018
8.2.1.3. Market
Forecast, 2019 – 2027
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2013 – 2018
8.2.1.5.1.2. Market
Forecast, 2019 – 2027
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2013 – 2018
8.2.1.5.2.2. Market
Forecast, 2019 – 2027
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2013 – 2018
8.2.1.5.3.2. Market
Forecast, 2019 – 2027
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2013 – 2018
8.2.1.5.4.2. Market
Forecast, 2019 – 2027
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2013 – 2018
8.2.1.5.5.2. Market
Forecast, 2019 – 2027
8.2.2. Medication
(Definition, Market Estimation and Penetration, 2013 – 2018, Market Estimation
(2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Naltrexone, Acamprosate,
Disulfiram, Buprenorphine, Methadone, Others)
8.2.2.1. Naltrexone
8.2.2.2. Acamprosate
8.2.2.3. Disulfiram
8.2.2.4. Buprenorphine
8.2.2.5. Methadone
8.2.2.6. Others
8.2.3. Behavioral
Therapies and Counseling (Definition, Market Estimation and Penetration, 2013 –
2018, Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound
Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia
Pacific, Middle East and Africa, Latin America) and Information on
Cognitive-Behavioral Therapy (CBT), Motivational Enhancement Therapy (MET),
Multidimensional Family Therapy, Dialectic Behavioural Therapy, Rational
Emotive Behavior Therapy (REBT) Therapy, Therapeutic Communities, Recovery
Housing, Self-help Groups, Online Counseling, Psychotherapy, Mindfulness,
Specialty Therapies, Others)
8.2.3.1. Cognitive-Behavioral
Therapy (CBT)
8.2.3.2. Motivational
Enhancement Therapy (MET)
8.2.3.3. Multidimensional
Family Therapy
8.2.3.4. Dialectic
Behavioural Therapy
8.2.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
8.2.3.6. Therapeutic
Communities
8.2.3.7. Recovery
Housing
8.2.3.8. Self-help
Groups
8.2.3.9. Online
Counseling
8.2.3.10. Psychotherapy
8.2.3.11. Mindfulness
8.2.3.12. Specialty
Therapies
8.2.3.12.1. Music
Therapy
8.2.3.12.2. Yoga
Therapy
8.2.3.12.3. Animal
Assisted Therapy
8.2.3.12.4. Art
Therapy
8.2.3.12.5. Others
8.2.3.13. Others
8.2.4. Substance
Abuse Services (Definition, Market Estimation and Penetration, 2013 – 2018,
Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual
Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific,
Middle East and Africa, Latin America) and Information on Vocational Services,
Mental Health Services, Medical Services, Educational Services, HIV/AIDS
Services, Legal Services, Family Services, Others)
8.2.4.1. Vocational
Services
8.2.4.2. Mental
Health Services
8.2.4.3. Medical
Services
8.2.4.4. Educational
Services
8.2.4.5. HIV/AIDS
Services
8.2.4.6. Legal Services
8.2.4.7. Family
Services
8.2.4.8. Others
8.2.5. Combination
Treatment
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2013 – 2018
8.2.5.3. Market
Forecast, 2019 – 2027
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2013 – 2018
8.2.5.5.1.2. Market
Forecast, 2019 – 2027
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2013 – 2018
8.2.5.5.2.2. Market
Forecast, 2019 – 2027
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2013 – 2018
8.2.5.5.3.2. Market
Forecast, 2019 – 2027
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2013 – 2018
8.2.5.5.4.2. Market
Forecast, 2019 – 2027
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2013 – 2018
8.2.5.5.5.2. Market
Forecast, 2019 – 2027
8.2.6. Others
8.2.6.1. Definition
8.2.6.2. Market
Estimation and Penetration, 2013 – 2018
8.2.6.3. Market
Forecast, 2019 – 2027
8.2.6.4. Compound
Annual Growth Rate (CAGR)
8.2.6.5. Regional
Bifurcation
8.2.6.5.1. North
America
8.2.6.5.1.1. Market
Estimation, 2013 – 2018
8.2.6.5.1.2. Market
Forecast, 2019 – 2027
8.2.6.5.2. Europe
8.2.6.5.2.1. Market
Estimation, 2013 – 2018
8.2.6.5.2.2. Market
Forecast, 2019 – 2027
8.2.6.5.3. Asia
Pacific
8.2.6.5.3.1. Market
Estimation, 2013 – 2018
8.2.6.5.3.2. Market
Forecast, 2019 – 2027
8.2.6.5.4. Middle
East and Africa
8.2.6.5.4.1. Market
Estimation, 2013 – 2018
8.2.6.5.4.2. Market
Forecast, 2019 – 2027
8.2.6.5.5. Latin
America
8.2.6.5.5.1. Market
Estimation, 2013 – 2018
8.2.6.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Treatment Type
9. Global Drug
Addiction Treatment Market Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Withdrawal
Symptoms
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2013 – 2018
9.2.1.3. Market
Forecast, 2019 – 2027
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2013 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2013 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2013 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2013 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2013 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Relapse
Prevention
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2013 – 2018
9.2.2.3. Market
Forecast, 2019 – 2027
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2013 – 2018
9.2.2.5.1.2. Market
Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2013 – 2018
9.2.2.5.2.2. Market
Forecast, 2019 – 2027
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2013 – 2018
9.2.2.5.3.2. Market
Forecast, 2019 – 2027
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2013 – 2018
9.2.2.5.4.2. Market
Forecast, 2019 – 2027
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2013 – 2018
9.2.2.5.5.2. Market
Forecast, 2019 – 2027
9.2.3. Co-Occurring
Conditions (Definition, Market Estimation and Penetration, 2013 – 2018, Market
Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Depression, Anxiety
Disorders (Including Post-Traumatic Stress Disorder), Bipolar Disorder,
Schizophrenia, Others)
9.2.3.1. Depression
9.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
9.2.3.3. Bipolar
Disorder
9.2.3.4. Schizophrenia
9.2.3.5. Others
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2013 – 2018
9.2.4.3. Market
Forecast, 2019 – 2027
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2013 – 2018
9.2.4.5.1.2. Market
Forecast, 2019 – 2027
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2013 – 2018
9.2.4.5.2.2. Market
Forecast, 2019 – 2027
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2013 – 2018
9.2.4.5.3.2. Market
Forecast, 2019 – 2027
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2013 – 2018
9.2.4.5.4.2. Market
Forecast, 2019 – 2027
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2013 – 2018
9.2.4.5.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. Global
Drug Addiction Treatment Market Analysis and Forecasts, 2019 – 2027
10.1. Overview
10.2. Global
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
10.2.1. Adolescents
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2013 – 2018
10.2.1.3. Market
Forecast, 2019 – 2027
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2013 – 2018
10.2.1.5.1.2. Market
Forecast, 2019 – 2027
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2013 – 2018
10.2.1.5.2.2. Market
Forecast, 2019 – 2027
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2013 – 2018
10.2.1.5.3.2. Market
Forecast, 2019 – 2027
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2013 – 2018
10.2.1.5.4.2. Market
Forecast, 2019 – 2027
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2013 – 2018
10.2.1.5.5.2. Market
Forecast, 2019 – 2027
10.2.2. Young
Adults
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2013 – 2018
10.2.2.3. Market
Forecast, 2019 – 2027
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2013 – 2018
10.2.2.5.1.2. Market
Forecast, 2019 – 2027
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2013 – 2018
10.2.2.5.2.2. Market
Forecast, 2019 – 2027
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2013 – 2018
10.2.2.5.3.2. Market
Forecast, 2019 – 2027
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2013 – 2018
10.2.2.5.4.2. Market
Forecast, 2019 – 2027
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2013 – 2018
10.2.2.5.5.2. Market
Forecast, 2019 – 2027
10.2.3. Adults
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2013 – 2018
10.2.3.3. Market
Forecast, 2019 – 2027
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2013 – 2018
10.2.3.5.1.2. Market
Forecast, 2019 – 2027
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2013 – 2018
10.2.3.5.2.2. Market
Forecast, 2019 – 2027
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2013 – 2018
10.2.3.5.3.2. Market
Forecast, 2019 – 2027
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2013 – 2018
10.2.3.5.4.2. Market
Forecast, 2019 – 2027
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2013 – 2018
10.2.3.5.5.2. Market
Forecast, 2019 – 2027
10.2.4. Elderly
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2013 – 2018
10.2.4.3. Market
Forecast, 2019 – 2027
10.2.4.4. Compound
Annual Growth Rate (CAGR)
10.2.4.5. Regional
Bifurcation
10.2.4.5.1. North
America
10.2.4.5.1.1. Market
Estimation, 2013 – 2018
10.2.4.5.1.2. Market
Forecast, 2019 – 2027
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2013 – 2018
10.2.4.5.2.2. Market
Forecast, 2019 – 2027
10.2.4.5.3. Asia
Pacific
10.2.4.5.3.1. Market
Estimation, 2013 – 2018
10.2.4.5.3.2. Market
Forecast, 2019 – 2027
10.2.4.5.4. Middle
East and Africa
10.2.4.5.4.1. Market
Estimation, 2013 – 2018
10.2.4.5.4.2. Market
Forecast, 2019 – 2027
10.2.4.5.5. Latin
America
10.2.4.5.5.1. Market
Estimation, 2013 – 2018
10.2.4.5.5.2. Market
Forecast, 2019 – 2027
10.3. Key
Segment for Channeling Investments
10.3.1. By Age
Group
11. Global
Drug Addiction Treatment Market Analysis and Forecasts, 2019 – 2027
11.1. Overview
11.2. Global
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
11.2.1. Illicit
Drugs (Definition, Market Estimation and Penetration, 2013 – 2018, Market
Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Cocaine, Crack Cocaine,
Ecstasy, Marijuana, Hallucinogens, Methamphetamine, Heroin, Others)
11.2.1.1. Cocaine
11.2.1.2. Crack
Cocaine
11.2.1.3. Ecstasy
11.2.1.4. Marijuana
11.2.1.5. Hallucinogens
11.2.1.6. Methamphetamine
11.2.1.7. Heroin
11.2.1.8. Others
11.2.2. Opiates/Opioids
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2013 – 2018
11.2.2.3. Market
Forecast, 2019 – 2027
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2013 – 2018
11.2.2.5.1.2. Market
Forecast, 2019 – 2027
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2013 – 2018
11.2.2.5.2.2. Market
Forecast, 2019 – 2027
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2013 – 2018
11.2.2.5.3.2. Market
Forecast, 2019 – 2027
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2013 – 2018
11.2.2.5.4.2. Market
Forecast, 2019 – 2027
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2013 – 2018
11.2.2.5.5.2. Market
Forecast, 2019 – 2027
11.2.3. Sleeping
Pills
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2013 – 2018
11.2.3.3. Market
Forecast, 2019 – 2027
11.2.3.4. Compound
Annual Growth Rate (CAGR)
11.2.3.5. Regional
Bifurcation
11.2.3.5.1. North
America
11.2.3.5.1.1. Market
Estimation, 2013 – 2018
11.2.3.5.1.2. Market
Forecast, 2019 – 2027
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2013 – 2018
11.2.3.5.2.2. Market
Forecast, 2019 – 2027
11.2.3.5.3. Asia
Pacific
11.2.3.5.3.1. Market
Estimation, 2013 – 2018
11.2.3.5.3.2. Market
Forecast, 2019 – 2027
11.2.3.5.4. Middle
East and Africa
11.2.3.5.4.1. Market
Estimation, 2013 – 2018
11.2.3.5.4.2. Market
Forecast, 2019 – 2027
11.2.3.5.5. Latin
America
11.2.3.5.5.1. Market
Estimation, 2013 – 2018
11.2.3.5.5.2. Market
Forecast, 2019 – 2027
11.2.4. Stimulants
11.2.4.1. Definition
11.2.4.2. Market
Estimation and Penetration, 2013 – 2018
11.2.4.3. Market
Forecast, 2019 – 2027
11.2.4.4. Compound
Annual Growth Rate (CAGR)
11.2.4.5. Regional
Bifurcation
11.2.4.5.1. North
America
11.2.4.5.1.1. Market
Estimation, 2013 – 2018
11.2.4.5.1.2. Market
Forecast, 2019 – 2027
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2013 – 2018
11.2.4.5.2.2. Market
Forecast, 2019 – 2027
11.2.4.5.3. Asia
Pacific
11.2.4.5.3.1. Market
Estimation, 2013 – 2018
11.2.4.5.3.2. Market
Forecast, 2019 – 2027
11.2.4.5.4. Middle
East and Africa
11.2.4.5.4.1. Market
Estimation, 2013 – 2018
11.2.4.5.4.2. Market
Forecast, 2019 – 2027
11.2.4.5.5. Latin
America
11.2.4.5.5.1. Market
Estimation, 2013 – 2018
11.2.4.5.5.2. Market
Forecast, 2019 – 2027
11.2.5. Others
11.2.5.1. Definition
11.2.5.2. Market
Estimation and Penetration, 2013 – 2018
11.2.5.3. Market
Forecast, 2019 – 2027
11.2.5.4. Compound
Annual Growth Rate (CAGR)
11.2.5.5. Regional
Bifurcation
11.2.5.5.1. North
America
11.2.5.5.1.1. Market
Estimation, 2013 – 2018
11.2.5.5.1.2. Market
Forecast, 2019 – 2027
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2013 – 2018
11.2.5.5.2.2. Market
Forecast, 2019 – 2027
11.2.5.5.3. Asia
Pacific
11.2.5.5.3.1. Market
Estimation, 2013 – 2018
11.2.5.5.3.2. Market
Forecast, 2019 – 2027
11.2.5.5.4. Middle
East and Africa
11.2.5.5.4.1. Market
Estimation, 2013 – 2018
11.2.5.5.4.2. Market
Forecast, 2019 – 2027
11.2.5.5.5. Latin
America
11.2.5.5.5.1. Market
Estimation, 2013 – 2018
11.2.5.5.5.2. Market
Forecast, 2019 – 2027
11.3. Key
Segment for Channeling Investments
11.3.1. By Drug
Type
12. Global
Drug Addiction Treatment Market Analysis and Forecasts, 2019 – 2027
12.1. Overview
12.2. Global
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
12.2.1. Mild
Substance Use Disorders
12.2.1.1. Definition
12.2.1.2. Market
Estimation and Penetration, 2013 – 2018
12.2.1.3. Market
Forecast, 2019 – 2027
12.2.1.4. Compound
Annual Growth Rate (CAGR)
12.2.1.5. Regional
Bifurcation
12.2.1.5.1. North
America
12.2.1.5.1.1. Market
Estimation, 2013 – 2018
12.2.1.5.1.2. Market
Forecast, 2019 – 2027
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2013 – 2018
12.2.1.5.2.2. Market
Forecast, 2019 – 2027
12.2.1.5.3. Asia
Pacific
12.2.1.5.3.1. Market
Estimation, 2013 – 2018
12.2.1.5.3.2. Market
Forecast, 2019 – 2027
12.2.1.5.4. Middle
East and Africa
12.2.1.5.4.1. Market
Estimation, 2013 – 2018
12.2.1.5.4.2. Market
Forecast, 2019 – 2027
12.2.1.5.5. Latin
America
12.2.1.5.5.1. Market
Estimation, 2013 – 2018
12.2.1.5.5.2. Market
Forecast, 2019 – 2027
12.2.2. Chronic
Substance Use Disorders
12.2.2.1. Definition
12.2.2.2. Market
Estimation and Penetration, 2013 – 2018
12.2.2.3. Market
Forecast, 2019 – 2027
12.2.2.4. Compound
Annual Growth Rate (CAGR)
12.2.2.5. Regional
Bifurcation
12.2.2.5.1. North
America
12.2.2.5.1.1. Market
Estimation, 2013 – 2018
12.2.2.5.1.2. Market
Forecast, 2019 – 2027
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2013 – 2018
12.2.2.5.2.2. Market
Forecast, 2019 – 2027
12.2.2.5.3. Asia
Pacific
12.2.2.5.3.1. Market
Estimation, 2013 – 2018
12.2.2.5.3.2. Market
Forecast, 2019 – 2027
12.2.2.5.4. Middle
East and Africa
12.2.2.5.4.1. Market
Estimation, 2013 – 2018
12.2.2.5.4.2. Market
Forecast, 2019 – 2027
12.2.2.5.5. Latin
America
12.2.2.5.5.1. Market
Estimation, 2013 – 2018
12.2.2.5.5.2. Market
Forecast, 2019 – 2027
12.3. Key
Segment for Channeling Investments
12.3.1. By
Addiction Type
13. Global
Drug Addiction Treatment Market Analysis and Forecasts, 2019 – 2027
13.1. Overview
13.2. Global
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
13.2.1. Hospitals/Clinics
13.2.1.1. Definition
13.2.1.2. Market
Estimation and Penetration, 2013 – 2018
13.2.1.3. Market
Forecast, 2019 – 2027
13.2.1.4. Compound
Annual Growth Rate (CAGR)
13.2.1.5. Regional
Bifurcation
13.2.1.5.1. North
America
13.2.1.5.1.1. Market
Estimation, 2013 – 2018
13.2.1.5.1.2. Market
Forecast, 2019 – 2027
13.2.1.5.2. Europe
13.2.1.5.2.1. Market
Estimation, 2013 – 2018
13.2.1.5.2.2. Market
Forecast, 2019 – 2027
13.2.1.5.3. Asia
Pacific
13.2.1.5.3.1. Market
Estimation, 2013 – 2018
13.2.1.5.3.2. Market
Forecast, 2019 – 2027
13.2.1.5.4. Middle
East and Africa
13.2.1.5.4.1. Market
Estimation, 2013 – 2018
13.2.1.5.4.2. Market
Forecast, 2019 – 2027
13.2.1.5.5. Latin
America
13.2.1.5.5.1. Market
Estimation, 2013 – 2018
13.2.1.5.5.2. Market
Forecast, 2019 – 2027
13.2.2. Rehabilitation
Centers
13.2.2.1. Definition
13.2.2.2. Market
Estimation and Penetration, 2013 – 2018
13.2.2.3. Market
Forecast, 2019 – 2027
13.2.2.4. Compound
Annual Growth Rate (CAGR)
13.2.2.5. Regional
Bifurcation
13.2.2.5.1. North
America
13.2.2.5.1.1. Market
Estimation, 2013 – 2018
13.2.2.5.1.2. Market
Forecast, 2019 – 2027
13.2.2.5.2. Europe
13.2.2.5.2.1. Market
Estimation, 2013 – 2018
13.2.2.5.2.2. Market
Forecast, 2019 – 2027
13.2.2.5.3. Asia
Pacific
13.2.2.5.3.1. Market
Estimation, 2013 – 2018
13.2.2.5.3.2. Market
Forecast, 2019 – 2027
13.2.2.5.4. Middle
East and Africa
13.2.2.5.4.1. Market
Estimation, 2013 – 2018
13.2.2.5.4.2. Market
Forecast, 2019 – 2027
13.2.2.5.5. Latin
America
13.2.2.5.5.1. Market
Estimation, 2013 – 2018
13.2.2.5.5.2. Market
Forecast, 2019 – 2027
13.2.3. Urgent
Care Centers
13.2.3.1. Definition
13.2.3.2. Market
Estimation and Penetration, 2013 – 2018
13.2.3.3. Market
Forecast, 2019 – 2027
13.2.3.4. Compound
Annual Growth Rate (CAGR)
13.2.3.5. Regional
Bifurcation
13.2.3.5.1. North
America
13.2.3.5.1.1. Market
Estimation, 2013 – 2018
13.2.3.5.1.2. Market
Forecast, 2019 – 2027
13.2.3.5.2. Europe
13.2.3.5.2.1. Market
Estimation, 2013 – 2018
13.2.3.5.2.2. Market
Forecast, 2019 – 2027
13.2.3.5.3. Asia
Pacific
13.2.3.5.3.1. Market
Estimation, 2013 – 2018
13.2.3.5.3.2. Market
Forecast, 2019 – 2027
13.2.3.5.4. Middle
East and Africa
13.2.3.5.4.1. Market
Estimation, 2013 – 2018
13.2.3.5.4.2. Market
Forecast, 2019 – 2027
13.2.3.5.5. Latin
America
13.2.3.5.5.1. Market
Estimation, 2013 – 2018
13.2.3.5.5.2. Market
Forecast, 2019 – 2027
13.2.4. Others
13.2.4.1. Definition
13.2.4.2. Market
Estimation and Penetration, 2013 – 2018
13.2.4.3. Market
Forecast, 2019 – 2027
13.2.4.4. Compound
Annual Growth Rate (CAGR)
13.2.4.5. Regional
Bifurcation
13.2.4.5.1. North
America
13.2.4.5.1.1. Market
Estimation, 2013 – 2018
13.2.4.5.1.2. Market
Forecast, 2019 – 2027
13.2.4.5.2. Europe
13.2.4.5.2.1. Market
Estimation, 2013 – 2018
13.2.4.5.2.2. Market
Forecast, 2019 – 2027
13.2.4.5.3. Asia
Pacific
13.2.4.5.3.1. Market
Estimation, 2013 – 2018
13.2.4.5.3.2. Market
Forecast, 2019 – 2027
13.2.4.5.4. Middle
East and Africa
13.2.4.5.4.1. Market
Estimation, 2013 – 2018
13.2.4.5.4.2. Market
Forecast, 2019 – 2027
13.2.4.5.5. Latin
America
13.2.4.5.5.1. Market
Estimation, 2013 – 2018
13.2.4.5.5.2. Market
Forecast, 2019 – 2027
13.3. Key
Segment for Channeling Investments
13.3.1. By
Providers
14. North
America Drug Addiction Treatment Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. North
America Drug Addiction Treatment Market Revenue (US$ Mn)
14.2. North
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
14.2.1. Detoxification
14.2.2. Medication
14.2.2.1. Naltrexone
14.2.2.2. Acamprosate
14.2.2.3. Disulfiram
14.2.2.4. Buprenorphine
14.2.2.5. Methadone
14.2.2.6. Others
14.2.3. Behavioral
Therapies and Counseling
14.2.3.1. Cognitive-Behavioral
Therapy (CBT)
14.2.3.2. Motivational
Enhancement Therapy (MET)
14.2.3.3. Multidimensional
Family Therapy
14.2.3.4. Dialectic
Behavioural Therapy
14.2.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
14.2.3.6. Therapeutic
Communities
14.2.3.7. Recovery
Housing
14.2.3.8. Self-help
Groups
14.2.3.9. Online
Counseling
14.2.3.10. Psychotherapy
14.2.3.11. Mindfulness
14.2.3.12. Specialty
Therapies
14.2.3.12.1. Music
Therapy
14.2.3.12.2. Yoga
Therapy
14.2.3.12.3. Animal
Assisted Therapy
14.2.3.12.4. Art
Therapy
14.2.3.12.5. Others
14.2.3.13. Others
14.2.4. Substance
Abuse Services
14.2.4.1. Vocational
Services
14.2.4.2. Mental
Health Services
14.2.4.3. Medical
Services
14.2.4.4. Educational
Services
14.2.4.5. HIV/AIDS
Services
14.2.4.6. Legal
Services
14.2.4.7. Family
Services
14.2.4.8. Others
14.2.5. Combination
Treatment
14.2.6. Others
14.3. North
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
14.3.1. Withdrawal
Symptoms
14.3.2. Relapse
Prevention
14.3.3. Co-Occurring
Conditions
14.3.3.1. Depression
14.3.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
14.3.3.3. Bipolar
Disorder
14.3.3.4. Schizophrenia
14.3.3.5. Others
14.3.4. Others
14.4. North
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
14.4.1. Adolescents
14.4.2. Young
Adults
14.4.3. Adults
14.4.4. Elderly
14.5. North
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug
Type
14.5.1. Illicit
Drugs
14.5.1.1. Cocaine
14.5.1.2. Crack
Cocaine
14.5.1.3. Ecstasy
14.5.1.4. Marijuana
14.5.1.5. Hallucinogens
14.5.1.6. Methamphetamine
14.5.1.7. Heroin
14.5.1.8. Others
14.5.2. Opiates/Opioids
14.5.3. Sleeping
Pills
14.5.4. Stimulants
14.5.5. Others
14.6. North
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
14.6.1. Mild
Substance Use Disorders
14.6.2. Chronic
Substance Use Disorders
14.7. North
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
14.7.1. Hospitals/Clinics
14.7.2. Rehabilitation
Centers
14.7.3. Urgent
Care Centers
14.7.4. Others
14.8. North
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Country
14.8.1. U.S
14.8.1.1. U.S
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
14.8.1.1.1. Detoxification
14.8.1.1.2. Medication
14.8.1.1.2.1. Naltrexone
14.8.1.1.2.2. Acamprosate
14.8.1.1.2.3. Disulfiram
14.8.1.1.2.4. Buprenorphine
14.8.1.1.2.5. Methadone
14.8.1.1.2.6. Others
14.8.1.1.3. Behavioral
Therapies and Counseling
14.8.1.1.3.1. Cognitive-Behavioral
Therapy (CBT)
14.8.1.1.3.2. Motivational
Enhancement Therapy (MET)
14.8.1.1.3.3. Multidimensional
Family Therapy
14.8.1.1.3.4. Dialectic
Behavioural Therapy
14.8.1.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
14.8.1.1.3.6. Therapeutic
Communities
14.8.1.1.3.7. Recovery
Housing
14.8.1.1.3.8. Self-help
Groups
14.8.1.1.3.9. Online
Counseling
14.8.1.1.3.10. Psychotherapy
14.8.1.1.3.11. Mindfulness
14.8.1.1.3.12. Specialty
Therapies
14.8.1.1.3.12.1. Music Therapy
14.8.1.1.3.12.2. Yoga Therapy
14.8.1.1.3.12.3. Animal Assisted Therapy
14.8.1.1.3.12.4. Art Therapy
14.8.1.1.3.12.5. Others
14.8.1.1.3.13. Others
14.8.1.1.4. Substance
Abuse Services
14.8.1.1.4.1. Vocational
Services
14.8.1.1.4.2. Mental
Health Services
14.8.1.1.4.3. Medical
Services
14.8.1.1.4.4. Educational
Services
14.8.1.1.4.5. HIV/AIDS
Services
14.8.1.1.4.6. Legal
Services
14.8.1.1.4.7. Family
Services
14.8.1.1.4.8. Others
14.8.1.1.5. Combination
Treatment
14.8.1.1.6. Others
14.8.1.2. U.S
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
14.8.1.2.1. Withdrawal
Symptoms
14.8.1.2.2. Relapse
Prevention
14.8.1.2.3. Co-Occurring
Conditions
14.8.1.2.3.1. Depression
14.8.1.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
14.8.1.2.3.3. Bipolar
Disorder
14.8.1.2.3.4. Schizophrenia
14.8.1.2.3.5. Others
14.8.1.2.4. Others
14.8.1.3. U.S
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
14.8.1.3.1. Adolescents
14.8.1.3.2. Young
Adults
14.8.1.3.3. Adults
14.8.1.3.4. Elderly
14.8.1.4. U.S
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.8.1.4.1. Illicit
Drugs
14.8.1.4.1.1. Cocaine
14.8.1.4.1.2. Crack
Cocaine
14.8.1.4.1.3. Ecstasy
14.8.1.4.1.4. Marijuana
14.8.1.4.1.5. Hallucinogens
14.8.1.4.1.6. Methamphetamine
14.8.1.4.1.7. Heroin
14.8.1.4.1.8. Others
14.8.1.4.2. Opiates/Opioids
14.8.1.4.3. Sleeping
Pills
14.8.1.4.4. Stimulants
14.8.1.4.5. Others
14.8.1.5. U.S
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
14.8.1.5.1. Mild
Substance Use Disorders
14.8.1.5.2. Chronic
Substance Use Disorders
14.8.1.6. U.S
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
14.8.1.6.1. Hospitals/Clinics
14.8.1.6.2. Rehabilitation
Centers
14.8.1.6.3. Urgent
Care Centers
14.8.1.6.4. Others
14.8.2. Canada
14.8.2.1. Canada
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
14.8.2.1.1. Detoxification
14.8.2.1.2. Medication
14.8.2.1.2.1. Naltrexone
14.8.2.1.2.2. Acamprosate
14.8.2.1.2.3. Disulfiram
14.8.2.1.2.4. Buprenorphine
14.8.2.1.2.5. Methadone
14.8.2.1.2.6. Others
14.8.2.1.3. Behavioral
Therapies and Counseling
14.8.2.1.3.1. Cognitive-Behavioral
Therapy (CBT)
14.8.2.1.3.2. Motivational
Enhancement Therapy (MET)
14.8.2.1.3.3. Multidimensional
Family Therapy
14.8.2.1.3.4. Dialectic
Behavioural Therapy
14.8.2.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
14.8.2.1.3.6. Therapeutic
Communities
14.8.2.1.3.7. Recovery
Housing
14.8.2.1.3.8. Self-help
Groups
14.8.2.1.3.9. Online
Counseling
14.8.2.1.3.10. Psychotherapy
14.8.2.1.3.11. Mindfulness
14.8.2.1.3.12. Specialty
Therapies
14.8.2.1.3.12.1. Music Therapy
14.8.2.1.3.12.2. Yoga Therapy
14.8.2.1.3.12.3. Animal Assisted Therapy
14.8.2.1.3.12.4. Art Therapy
14.8.2.1.3.12.5. Others
14.8.2.1.3.13. Others
14.8.2.1.4. Substance
Abuse Services
14.8.2.1.4.1. Vocational
Services
14.8.2.1.4.2. Mental
Health Services
14.8.2.1.4.3. Medical
Services
14.8.2.1.4.4. Educational
Services
14.8.2.1.4.5. HIV/AIDS
Services
14.8.2.1.4.6. Legal
Services
14.8.2.1.4.7. Family
Services
14.8.2.1.4.8. Others
14.8.2.1.5. Combination
Treatment
14.8.2.1.6. Others
14.8.2.2. Canada
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
14.8.2.2.1. Withdrawal
Symptoms
14.8.2.2.2. Relapse
Prevention
14.8.2.2.3. Co-Occurring
Conditions
14.8.2.2.3.1. Depression
14.8.2.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
14.8.2.2.3.3. Bipolar
Disorder
14.8.2.2.3.4. Schizophrenia
14.8.2.2.3.5. Others
14.8.2.2.4. Others
14.8.2.3. Canada
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
14.8.2.3.1. Adolescents
14.8.2.3.2. Young
Adults
14.8.2.3.3. Adults
14.8.2.3.4. Elderly
14.8.2.4. Canada
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.8.2.4.1. Illicit
Drugs
14.8.2.4.1.1. Cocaine
14.8.2.4.1.2. Crack
Cocaine
14.8.2.4.1.3. Ecstasy
14.8.2.4.1.4. Marijuana
14.8.2.4.1.5. Hallucinogens
14.8.2.4.1.6. Methamphetamine
14.8.2.4.1.7. Heroin
14.8.2.4.1.8. Others
14.8.2.4.2. Opiates/Opioids
14.8.2.4.3. Sleeping
Pills
14.8.2.4.4. Stimulants
14.8.2.4.5. Others
14.8.2.5. Canada
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
14.8.2.5.1. Mild
Substance Use Disorders
14.8.2.5.2. Chronic
Substance Use Disorders
14.8.2.6. Canada
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
14.8.2.6.1. Hospitals/Clinics
14.8.2.6.2. Rehabilitation
Centers
14.8.2.6.3. Urgent
Care Centers
14.8.2.6.4. Others
14.8.3. Mexico
14.8.3.1. Mexico
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
14.8.3.1.1. Detoxification
14.8.3.1.2. Medication
14.8.3.1.2.1. Naltrexone
14.8.3.1.2.2. Acamprosate
14.8.3.1.2.3. Disulfiram
14.8.3.1.2.4. Buprenorphine
14.8.3.1.2.5. Methadone
14.8.3.1.2.6. Others
14.8.3.1.3. Behavioral
Therapies and Counseling
14.8.3.1.3.1. Cognitive-Behavioral
Therapy (CBT)
14.8.3.1.3.2. Motivational
Enhancement Therapy (MET)
14.8.3.1.3.3. Multidimensional
Family Therapy
14.8.3.1.3.4. Dialectic
Behavioural Therapy
14.8.3.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
14.8.3.1.3.6. Therapeutic
Communities
14.8.3.1.3.7. Recovery
Housing
14.8.3.1.3.8. Self-help
Groups
14.8.3.1.3.9. Online
Counseling
14.8.3.1.3.10. Psychotherapy
14.8.3.1.3.11. Mindfulness
14.8.3.1.3.12. Specialty
Therapies
14.8.3.1.3.12.1. Music Therapy
14.8.3.1.3.12.2. Yoga Therapy
14.8.3.1.3.12.3. Animal Assisted Therapy
14.8.3.1.3.12.4. Art Therapy
14.8.3.1.3.12.5. Others
14.8.3.1.3.13. Others
14.8.3.1.4. Substance
Abuse Services
14.8.3.1.4.1. Vocational
Services
14.8.3.1.4.2. Mental
Health Services
14.8.3.1.4.3. Medical
Services
14.8.3.1.4.4. Educational
Services
14.8.3.1.4.5. HIV/AIDS
Services
14.8.3.1.4.6. Legal
Services
14.8.3.1.4.7. Family
Services
14.8.3.1.4.8. Others
14.8.3.1.5. Combination
Treatment
14.8.3.1.6. Others
14.8.3.2. Mexico
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
14.8.3.2.1. Withdrawal
Symptoms
14.8.3.2.2. Relapse
Prevention
14.8.3.2.3. Co-Occurring
Conditions
14.8.3.2.3.1. Depression
14.8.3.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
14.8.3.2.3.3. Bipolar
Disorder
14.8.3.2.3.4. Schizophrenia
14.8.3.2.3.5. Others
14.8.3.2.4. Others
14.8.3.3. Mexico
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
14.8.3.3.1. Adolescents
14.8.3.3.2. Young
Adults
14.8.3.3.3. Adults
14.8.3.3.4. Elderly
14.8.3.4. Mexico
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
14.8.3.4.1. Illicit
Drugs
14.8.3.4.1.1. Cocaine
14.8.3.4.1.2. Crack
Cocaine
14.8.3.4.1.3. Ecstasy
14.8.3.4.1.4. Marijuana
14.8.3.4.1.5. Hallucinogens
14.8.3.4.1.6. Methamphetamine
14.8.3.4.1.7. Heroin
14.8.3.4.1.8. Others
14.8.3.4.2. Opiates/Opioids
14.8.3.4.3. Sleeping
Pills
14.8.3.4.4. Stimulants
14.8.3.4.5. Others
14.8.3.5. Mexico
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
14.8.3.5.1. Mild
Substance Use Disorders
14.8.3.5.2. Chronic
Substance Use Disorders
14.8.3.6. Mexico
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
14.8.3.6.1. Hospitals/Clinics
14.8.3.6.2. Rehabilitation
Centers
14.8.3.6.3. Urgent
Care Centers
14.8.3.6.4. Others
14.8.4. Rest of
North America
14.8.4.1. Rest
of North America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Treatment Type
14.8.4.1.1. Detoxification
14.8.4.1.2. Medication
14.8.4.1.2.1. Naltrexone
14.8.4.1.2.2. Acamprosate
14.8.4.1.2.3. Disulfiram
14.8.4.1.2.4. Buprenorphine
14.8.4.1.2.5. Methadone
14.8.4.1.2.6. Others
14.8.4.1.3. Behavioral
Therapies and Counseling
14.8.4.1.3.1. Cognitive-Behavioral
Therapy (CBT)
14.8.4.1.3.2. Motivational
Enhancement Therapy (MET)
14.8.4.1.3.3. Multidimensional
Family Therapy
14.8.4.1.3.4. Dialectic
Behavioural Therapy
14.8.4.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
14.8.4.1.3.6. Therapeutic
Communities
14.8.4.1.3.7. Recovery
Housing
14.8.4.1.3.8. Self-help
Groups
14.8.4.1.3.9. Online
Counseling
14.8.4.1.3.10. Psychotherapy
14.8.4.1.3.11. Mindfulness
14.8.4.1.3.12. Specialty
Therapies
14.8.4.1.3.12.1. Music Therapy
14.8.4.1.3.12.2. Yoga Therapy
14.8.4.1.3.12.3. Animal Assisted Therapy
14.8.4.1.3.12.4. Art Therapy
14.8.4.1.3.12.5. Others
14.8.4.1.3.13. Others
14.8.4.1.4. Substance
Abuse Services
14.8.4.1.4.1. Vocational
Services
14.8.4.1.4.2. Mental
Health Services
14.8.4.1.4.3. Medical
Services
14.8.4.1.4.4. Educational
Services
14.8.4.1.4.5. HIV/AIDS
Services
14.8.4.1.4.6. Legal
Services
14.8.4.1.4.7. Family
Services
14.8.4.1.4.8. Others
14.8.4.1.5. Combination
Treatment
14.8.4.1.6. Others
14.8.4.2. Rest
of North America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Application
14.8.4.2.1. Withdrawal
Symptoms
14.8.4.2.2. Relapse
Prevention
14.8.4.2.3. Co-Occurring
Conditions
14.8.4.2.3.1. Depression
14.8.4.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
14.8.4.2.3.3. Bipolar
Disorder
14.8.4.2.3.4. Schizophrenia
14.8.4.2.3.5. Others
14.8.4.2.4. Others
14.8.4.3. Rest
of North America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Age Group
14.8.4.3.1. Adolescents
14.8.4.3.2. Young
Adults
14.8.4.3.3. Adults
14.8.4.3.4. Elderly
14.8.4.4. Rest
of North America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Drug Type
14.8.4.4.1. Illicit
Drugs
14.8.4.4.1.1. Cocaine
14.8.4.4.1.2. Crack
Cocaine
14.8.4.4.1.3. Ecstasy
14.8.4.4.1.4. Marijuana
14.8.4.4.1.5. Hallucinogens
14.8.4.4.1.6. Methamphetamine
14.8.4.4.1.7. Heroin
14.8.4.4.1.8. Others
14.8.4.4.2. Opiates/Opioids
14.8.4.4.3. Sleeping
Pills
14.8.4.4.4. Stimulants
14.8.4.4.5. Others
14.8.4.5. Rest
of North America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Addiction Type
14.8.4.5.1. Mild
Substance Use Disorders
14.8.4.5.2. Chronic
Substance Use Disorders
14.8.4.6. Rest
of North America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Providers
14.8.4.6.1. Hospitals/Clinics
14.8.4.6.2. Rehabilitation
Centers
14.8.4.6.3. Urgent
Care Centers
14.8.4.6.4. Others
14.9. Key
Segment for Channeling Investments
14.9.1. By
Country
14.9.2. By
Treatment Type
14.9.3. By
Application
14.9.4. By Age
Group
14.9.5. By Drug
Type
14.9.6. By
Addiction Type
14.9.7. By
Providers
15. Europe
Drug Addiction Treatment Market Analysis and Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Europe
Drug Addiction Treatment Market Revenue (US$ Mn)
15.2. Europe
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
15.2.1. Detoxification
15.2.2. Medication
15.2.2.1. Naltrexone
15.2.2.2. Acamprosate
15.2.2.3. Disulfiram
15.2.2.4. Buprenorphine
15.2.2.5. Methadone
15.2.2.6. Others
15.2.3. Behavioral
Therapies and Counseling
15.2.3.1. Cognitive-Behavioral
Therapy (CBT)
15.2.3.2. Motivational
Enhancement Therapy (MET)
15.2.3.3. Multidimensional
Family Therapy
15.2.3.4. Dialectic
Behavioural Therapy
15.2.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
15.2.3.6. Therapeutic
Communities
15.2.3.7. Recovery
Housing
15.2.3.8. Self-help
Groups
15.2.3.9. Online
Counseling
15.2.3.10. Psychotherapy
15.2.3.11. Mindfulness
15.2.3.12. Specialty
Therapies
15.2.3.12.1. Music
Therapy
15.2.3.12.2. Yoga
Therapy
15.2.3.12.3. Animal
Assisted Therapy
15.2.3.12.4. Art
Therapy
15.2.3.12.5. Others
15.2.3.13. Others
15.2.4. Substance
Abuse Services
15.2.4.1. Vocational
Services
15.2.4.2. Mental
Health Services
15.2.4.3. Medical
Services
15.2.4.4. Educational
Services
15.2.4.5. HIV/AIDS
Services
15.2.4.6. Legal
Services
15.2.4.7. Family
Services
15.2.4.8. Others
15.2.5. Combination
Treatment
15.2.6. Others
15.3. Europe
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
15.3.1. Withdrawal
Symptoms
15.3.2. Relapse
Prevention
15.3.3. Co-Occurring
Conditions
15.3.3.1. Depression
15.3.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
15.3.3.3. Bipolar
Disorder
15.3.3.4. Schizophrenia
15.3.3.5. Others
15.3.4. Others
15.4. Europe
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.4.1. Adolescents
15.4.2. Young
Adults
15.4.3. Adults
15.4.4. Elderly
15.5. Europe
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
15.5.1. Illicit
Drugs
15.5.1.1. Cocaine
15.5.1.2. Crack
Cocaine
15.5.1.3. Ecstasy
15.5.1.4. Marijuana
15.5.1.5. Hallucinogens
15.5.1.6. Methamphetamine
15.5.1.7. Heroin
15.5.1.8. Others
15.5.2. Opiates/Opioids
15.5.3. Sleeping
Pills
15.5.4. Stimulants
15.5.5. Others
15.6. Europe
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
15.6.1. Mild
Substance Use Disorders
15.6.2. Chronic
Substance Use Disorders
15.7. Europe
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
15.7.1. Hospitals/Clinics
15.7.2. Rehabilitation
Centers
15.7.3. Urgent
Care Centers
15.7.4. Others
15.8. Europe
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Country
15.8.1. France
15.8.1.1. France
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
15.8.1.1.1. Detoxification
15.8.1.1.2. Medication
15.8.1.1.2.1. Naltrexone
15.8.1.1.2.2. Acamprosate
15.8.1.1.2.3. Disulfiram
15.8.1.1.2.4. Buprenorphine
15.8.1.1.2.5. Methadone
15.8.1.1.2.6. Others
15.8.1.1.3. Behavioral
Therapies and Counseling
15.8.1.1.3.1. Cognitive-Behavioral
Therapy (CBT)
15.8.1.1.3.2. Motivational
Enhancement Therapy (MET)
15.8.1.1.3.3. Multidimensional
Family Therapy
15.8.1.1.3.4. Dialectic
Behavioural Therapy
15.8.1.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
15.8.1.1.3.6. Therapeutic
Communities
15.8.1.1.3.7. Recovery
Housing
15.8.1.1.3.8. Self-help
Groups
15.8.1.1.3.9. Online
Counseling
15.8.1.1.3.10. Psychotherapy
15.8.1.1.3.11. Mindfulness
15.8.1.1.3.12. Specialty
Therapies
15.8.1.1.3.12.1. Music Therapy
15.8.1.1.3.12.2. Yoga Therapy
15.8.1.1.3.12.3. Animal Assisted Therapy
15.8.1.1.3.12.4. Art Therapy
15.8.1.1.3.12.5. Others
15.8.1.1.3.13. Others
15.8.1.1.4. Substance
Abuse Services
15.8.1.1.4.1. Vocational
Services
15.8.1.1.4.2. Mental
Health Services
15.8.1.1.4.3. Medical
Services
15.8.1.1.4.4. Educational
Services
15.8.1.1.4.5. HIV/AIDS
Services
15.8.1.1.4.6. Legal
Services
15.8.1.1.4.7. Family
Services
15.8.1.1.4.8. Others
15.8.1.1.5. Combination
Treatment
15.8.1.1.6. Others
15.8.1.2. France
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
15.8.1.2.1. Withdrawal
Symptoms
15.8.1.2.2. Relapse
Prevention
15.8.1.2.3. Co-Occurring
Conditions
15.8.1.2.3.1. Depression
15.8.1.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
15.8.1.2.3.3. Bipolar
Disorder
15.8.1.2.3.4. Schizophrenia
15.8.1.2.3.5. Others
15.8.1.2.4. Others
15.8.1.3. France
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.1.3.1. Adolescents
15.8.1.3.2. Young
Adults
15.8.1.3.3. Adults
15.8.1.3.4. Elderly
15.8.1.4. France
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
15.8.1.4.1. Illicit
Drugs
15.8.1.4.1.1. Cocaine
15.8.1.4.1.2. Crack
Cocaine
15.8.1.4.1.3. Ecstasy
15.8.1.4.1.4. Marijuana
15.8.1.4.1.5. Hallucinogens
15.8.1.4.1.6. Methamphetamine
15.8.1.4.1.7. Heroin
15.8.1.4.1.8. Others
15.8.1.4.2. Opiates/Opioids
15.8.1.4.3. Sleeping
Pills
15.8.1.4.4. Stimulants
15.8.1.4.5. Others
15.8.1.5. France
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
15.8.1.5.1. Mild
Substance Use Disorders
15.8.1.5.2. Chronic
Substance Use Disorders
15.8.1.6. France
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
15.8.1.6.1. Hospitals/Clinics
15.8.1.6.2. Rehabilitation
Centers
15.8.1.6.3. Urgent
Care Centers
15.8.1.6.4. Others
15.8.2. The UK
15.8.2.1. The
UK Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
15.8.2.1.1. Detoxification
15.8.2.1.2. Medication
15.8.2.1.2.1. Naltrexone
15.8.2.1.2.2. Acamprosate
15.8.2.1.2.3. Disulfiram
15.8.2.1.2.4. Buprenorphine
15.8.2.1.2.5. Methadone
15.8.2.1.2.6. Others
15.8.2.1.3. Behavioral
Therapies and Counseling
15.8.2.1.3.1. Cognitive-Behavioral
Therapy (CBT)
15.8.2.1.3.2. Motivational
Enhancement Therapy (MET)
15.8.2.1.3.3. Multidimensional
Family Therapy
15.8.2.1.3.4. Dialectic
Behavioural Therapy
15.8.2.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
15.8.2.1.3.6. Therapeutic
Communities
15.8.2.1.3.7. Recovery
Housing
15.8.2.1.3.8. Self-help
Groups
15.8.2.1.3.9. Online
Counseling
15.8.2.1.3.10. Psychotherapy
15.8.2.1.3.11. Mindfulness
15.8.2.1.3.12. Specialty
Therapies
15.8.2.1.3.12.1. Music Therapy
15.8.2.1.3.12.2. Yoga Therapy
15.8.2.1.3.12.3. Animal Assisted Therapy
15.8.2.1.3.12.4. Art Therapy
15.8.2.1.3.12.5. Others
15.8.2.1.3.13. Others
15.8.2.1.4. Substance
Abuse Services
15.8.2.1.4.1. Vocational
Services
15.8.2.1.4.2. Mental
Health Services
15.8.2.1.4.3. Medical
Services
15.8.2.1.4.4. Educational
Services
15.8.2.1.4.5. HIV/AIDS
Services
15.8.2.1.4.6. Legal
Services
15.8.2.1.4.7. Family
Services
15.8.2.1.4.8. Others
15.8.2.1.5. Combination
Treatment
15.8.2.1.6. Others
15.8.2.2. The
UK Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
15.8.2.2.1. Withdrawal
Symptoms
15.8.2.2.2. Relapse
Prevention
15.8.2.2.3. Co-Occurring
Conditions
15.8.2.2.3.1. Depression
15.8.2.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
15.8.2.2.3.3. Bipolar
Disorder
15.8.2.2.3.4. Schizophrenia
15.8.2.2.3.5. Others
15.8.2.2.4. Others
15.8.2.3. The
UK Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.2.3.1. Adolescents
15.8.2.3.2. Young
Adults
15.8.2.3.3. Adults
15.8.2.3.4. Elderly
15.8.2.4. The
UK Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
15.8.2.4.1. Illicit
Drugs
15.8.2.4.1.1. Cocaine
15.8.2.4.1.2. Crack
Cocaine
15.8.2.4.1.3. Ecstasy
15.8.2.4.1.4. Marijuana
15.8.2.4.1.5. Hallucinogens
15.8.2.4.1.6. Methamphetamine
15.8.2.4.1.7. Heroin
15.8.2.4.1.8. Others
15.8.2.4.2. Opiates/Opioids
15.8.2.4.3. Sleeping
Pills
15.8.2.4.4. Stimulants
15.8.2.4.5. Others
15.8.2.5. The
UK Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
15.8.2.5.1. Mild
Substance Use Disorders
15.8.2.5.2. Chronic
Substance Use Disorders
15.8.2.6. The
UK Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
15.8.2.6.1. Hospitals/Clinics
15.8.2.6.2. Rehabilitation
Centers
15.8.2.6.3. Urgent
Care Centers
15.8.2.6.4. Others
15.8.3. Spain
15.8.3.1. Spain
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
15.8.3.1.1. Detoxification
15.8.3.1.2. Medication
15.8.3.1.2.1. Naltrexone
15.8.3.1.2.2. Acamprosate
15.8.3.1.2.3. Disulfiram
15.8.3.1.2.4. Buprenorphine
15.8.3.1.2.5. Methadone
15.8.3.1.2.6. Others
15.8.3.1.3. Behavioral
Therapies and Counseling
15.8.3.1.3.1. Cognitive-Behavioral
Therapy (CBT)
15.8.3.1.3.2. Motivational
Enhancement Therapy (MET)
15.8.3.1.3.3. Multidimensional
Family Therapy
15.8.3.1.3.4. Dialectic
Behavioural Therapy
15.8.3.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
15.8.3.1.3.6. Therapeutic
Communities
15.8.3.1.3.7. Recovery
Housing
15.8.3.1.3.8. Self-help
Groups
15.8.3.1.3.9. Online
Counseling
15.8.3.1.3.10. Psychotherapy
15.8.3.1.3.11. Mindfulness
15.8.3.1.3.12. Specialty
Therapies
15.8.3.1.3.12.1. Music Therapy
15.8.3.1.3.12.2. Yoga Therapy
15.8.3.1.3.12.3. Animal Assisted Therapy
15.8.3.1.3.12.4. Art Therapy
15.8.3.1.3.12.5. Others
15.8.3.1.3.13. Others
15.8.3.1.4. Substance
Abuse Services
15.8.3.1.4.1. Vocational
Services
15.8.3.1.4.2. Mental
Health Services
15.8.3.1.4.3. Medical
Services
15.8.3.1.4.4. Educational
Services
15.8.3.1.4.5. HIV/AIDS
Services
15.8.3.1.4.6. Legal
Services
15.8.3.1.4.7. Family
Services
15.8.3.1.4.8. Others
15.8.3.1.5. Combination
Treatment
15.8.3.1.6. Others
15.8.3.2. Spain
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
15.8.3.2.1. Withdrawal
Symptoms
15.8.3.2.2. Relapse
Prevention
15.8.3.2.3. Co-Occurring
Conditions
15.8.3.2.3.1. Depression
15.8.3.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
15.8.3.2.3.3. Bipolar
Disorder
15.8.3.2.3.4. Schizophrenia
15.8.3.2.3.5. Others
15.8.3.2.4. Others
15.8.3.3. Spain
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.3.3.1. Adolescents
15.8.3.3.2. Young
Adults
15.8.3.3.3. Adults
15.8.3.3.4. Elderly
15.8.3.4. Spain
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
15.8.3.4.1. Illicit
Drugs
15.8.3.4.1.1. Cocaine
15.8.3.4.1.2. Crack
Cocaine
15.8.3.4.1.3. Ecstasy
15.8.3.4.1.4. Marijuana
15.8.3.4.1.5. Hallucinogens
15.8.3.4.1.6. Methamphetamine
15.8.3.4.1.7. Heroin
15.8.3.4.1.8. Others
15.8.3.4.2. Opiates/Opioids
15.8.3.4.3. Sleeping
Pills
15.8.3.4.4. Stimulants
15.8.3.4.5. Others
15.8.3.5. Spain
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
15.8.3.5.1. Mild
Substance Use Disorders
15.8.3.5.2. Chronic
Substance Use Disorders
15.8.3.6. Spain
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
15.8.3.6.1. Hospitals/Clinics
15.8.3.6.2. Rehabilitation
Centers
15.8.3.6.3. Urgent
Care Centers
15.8.3.6.4. Others
15.8.4. Germany
15.8.4.1. Germany
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
15.8.4.1.1. Detoxification
15.8.4.1.2. Medication
15.8.4.1.2.1. Naltrexone
15.8.4.1.2.2. Acamprosate
15.8.4.1.2.3. Disulfiram
15.8.4.1.2.4. Buprenorphine
15.8.4.1.2.5. Methadone
15.8.4.1.2.6. Others
15.8.4.1.3. Behavioral
Therapies and Counseling
15.8.4.1.3.1. Cognitive-Behavioral
Therapy (CBT)
15.8.4.1.3.2. Motivational
Enhancement Therapy (MET)
15.8.4.1.3.3. Multidimensional
Family Therapy
15.8.4.1.3.4. Dialectic
Behavioural Therapy
15.8.4.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
15.8.4.1.3.6. Therapeutic
Communities
15.8.4.1.3.7. Recovery
Housing
15.8.4.1.3.8. Self-help
Groups
15.8.4.1.3.9. Online
Counseling
15.8.4.1.3.10. Psychotherapy
15.8.4.1.3.11. Mindfulness
15.8.4.1.3.12. Specialty
Therapies
15.8.4.1.3.12.1. Music Therapy
15.8.4.1.3.12.2. Yoga Therapy
15.8.4.1.3.12.3. Animal Assisted Therapy
15.8.4.1.3.12.4. Art Therapy
15.8.4.1.3.12.5. Others
15.8.4.1.3.13. Others
15.8.4.1.4. Substance
Abuse Services
15.8.4.1.4.1. Vocational
Services
15.8.4.1.4.2. Mental
Health Services
15.8.4.1.4.3. Medical
Services
15.8.4.1.4.4. Educational
Services
15.8.4.1.4.5. HIV/AIDS
Services
15.8.4.1.4.6. Legal
Services
15.8.4.1.4.7. Family
Services
15.8.4.1.4.8. Others
15.8.4.1.5. Combination
Treatment
15.8.4.1.6. Others
15.8.4.2. Germany
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
15.8.4.2.1. Withdrawal
Symptoms
15.8.4.2.2. Relapse
Prevention
15.8.4.2.3. Co-Occurring
Conditions
15.8.4.2.3.1. Depression
15.8.4.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
15.8.4.2.3.3. Bipolar
Disorder
15.8.4.2.3.4. Schizophrenia
15.8.4.2.3.5. Others
15.8.4.2.4. Others
15.8.4.3. Germany
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.4.3.1. Adolescents
15.8.4.3.2. Young
Adults
15.8.4.3.3. Adults
15.8.4.3.4. Elderly
15.8.4.4. Germany
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
15.8.4.4.1. Illicit
Drugs
15.8.4.4.1.1. Cocaine
15.8.4.4.1.2. Crack
Cocaine
15.8.4.4.1.3. Ecstasy
15.8.4.4.1.4. Marijuana
15.8.4.4.1.5. Hallucinogens
15.8.4.4.1.6. Methamphetamine
15.8.4.4.1.7. Heroin
15.8.4.4.1.8. Others
15.8.4.4.2. Opiates/Opioids
15.8.4.4.3. Sleeping
Pills
15.8.4.4.4. Stimulants
15.8.4.4.5. Others
15.8.4.5. Germany
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
15.8.4.5.1. Mild
Substance Use Disorders
15.8.4.5.2. Chronic
Substance Use Disorders
15.8.4.6. Germany
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
15.8.4.6.1. Hospitals/Clinics
15.8.4.6.2. Rehabilitation
Centers
15.8.4.6.3. Urgent
Care Centers
15.8.4.6.4. Others
15.8.5. Italy
15.8.5.1. Italy
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
15.8.5.1.1. Detoxification
15.8.5.1.2. Medication
15.8.5.1.2.1. Naltrexone
15.8.5.1.2.2. Acamprosate
15.8.5.1.2.3. Disulfiram
15.8.5.1.2.4. Buprenorphine
15.8.5.1.2.5. Methadone
15.8.5.1.2.6. Others
15.8.5.1.3. Behavioral
Therapies and Counseling
15.8.5.1.3.1. Cognitive-Behavioral
Therapy (CBT)
15.8.5.1.3.2. Motivational
Enhancement Therapy (MET)
15.8.5.1.3.3. Multidimensional
Family Therapy
15.8.5.1.3.4. Dialectic
Behavioural Therapy
15.8.5.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
15.8.5.1.3.6. Therapeutic
Communities
15.8.5.1.3.7. Recovery
Housing
15.8.5.1.3.8. Self-help
Groups
15.8.5.1.3.9. Online
Counseling
15.8.5.1.3.10. Psychotherapy
15.8.5.1.3.11. Mindfulness
15.8.5.1.3.12. Specialty
Therapies
15.8.5.1.3.12.1. Music Therapy
15.8.5.1.3.12.2. Yoga Therapy
15.8.5.1.3.12.3. Animal Assisted Therapy
15.8.5.1.3.12.4. Art Therapy
15.8.5.1.3.12.5. Others
15.8.5.1.3.13. Others
15.8.5.1.4. Substance
Abuse Services
15.8.5.1.4.1. Vocational
Services
15.8.5.1.4.2. Mental
Health Services
15.8.5.1.4.3. Medical
Services
15.8.5.1.4.4. Educational
Services
15.8.5.1.4.5. HIV/AIDS
Services
15.8.5.1.4.6. Legal
Services
15.8.5.1.4.7. Family
Services
15.8.5.1.4.8. Others
15.8.5.1.5. Combination
Treatment
15.8.5.1.6. Others
15.8.5.2. Italy
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
15.8.5.2.1. Withdrawal
Symptoms
15.8.5.2.2. Relapse
Prevention
15.8.5.2.3. Co-Occurring
Conditions
15.8.5.2.3.1. Depression
15.8.5.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
15.8.5.2.3.3. Bipolar
Disorder
15.8.5.2.3.4. Schizophrenia
15.8.5.2.3.5. Others
15.8.5.2.4. Others
15.8.5.3. Italy
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.5.3.1. Adolescents
15.8.5.3.2. Young
Adults
15.8.5.3.3. Adults
15.8.5.3.4. Elderly
15.8.5.4. Italy
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
15.8.5.4.1. Illicit
Drugs
15.8.5.4.1.1. Cocaine
15.8.5.4.1.2. Crack
Cocaine
15.8.5.4.1.3. Ecstasy
15.8.5.4.1.4. Marijuana
15.8.5.4.1.5. Hallucinogens
15.8.5.4.1.6. Methamphetamine
15.8.5.4.1.7. Heroin
15.8.5.4.1.8. Others
15.8.5.4.2. Opiates/Opioids
15.8.5.4.3. Sleeping
Pills
15.8.5.4.4. Stimulants
15.8.5.4.5. Others
15.8.5.5. Italy
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
15.8.5.5.1. Mild
Substance Use Disorders
15.8.5.5.2. Chronic
Substance Use Disorders
15.8.5.6. Italy
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
15.8.5.6.1. Hospitals/Clinics
15.8.5.6.2. Rehabilitation
Centers
15.8.5.6.3. Urgent
Care Centers
15.8.5.6.4. Others
15.8.6. Nordic Countries
15.8.6.1. Nordic
Countries Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
15.8.6.1.1. Detoxification
15.8.6.1.2. Medication
15.8.6.1.2.1. Naltrexone
15.8.6.1.2.2. Acamprosate
15.8.6.1.2.3. Disulfiram
15.8.6.1.2.4. Buprenorphine
15.8.6.1.2.5. Methadone
15.8.6.1.2.6. Others
15.8.6.1.3. Behavioral
Therapies and Counseling
15.8.6.1.3.1. Cognitive-Behavioral
Therapy (CBT)
15.8.6.1.3.2. Motivational
Enhancement Therapy (MET)
15.8.6.1.3.3. Multidimensional
Family Therapy
15.8.6.1.3.4. Dialectic
Behavioural Therapy
15.8.6.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
15.8.6.1.3.6. Therapeutic
Communities
15.8.6.1.3.7. Recovery
Housing
15.8.6.1.3.8. Self-help
Groups
15.8.6.1.3.9. Online
Counseling
15.8.6.1.3.10. Psychotherapy
15.8.6.1.3.11. Mindfulness
15.8.6.1.3.12. Specialty
Therapies
15.8.6.1.3.12.1. Music Therapy
15.8.6.1.3.12.2. Yoga Therapy
15.8.6.1.3.12.3. Animal Assisted Therapy
15.8.6.1.3.12.4. Art Therapy
15.8.6.1.3.12.5. Others
15.8.6.1.3.13. Others
15.8.6.1.4. Substance
Abuse Services
15.8.6.1.4.1. Vocational
Services
15.8.6.1.4.2. Mental
Health Services
15.8.6.1.4.3. Medical
Services
15.8.6.1.4.4. Educational
Services
15.8.6.1.4.5. HIV/AIDS
Services
15.8.6.1.4.6. Legal
Services
15.8.6.1.4.7. Family
Services
15.8.6.1.4.8. Others
15.8.6.1.5. Combination
Treatment
15.8.6.1.6. Others
15.8.6.2. Nordic
Countries Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
15.8.6.2.1. Withdrawal
Symptoms
15.8.6.2.2. Relapse
Prevention
15.8.6.2.3. Co-Occurring
Conditions
15.8.6.2.3.1. Depression
15.8.6.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
15.8.6.2.3.3. Bipolar
Disorder
15.8.6.2.3.4. Schizophrenia
15.8.6.2.3.5. Others
15.8.6.2.4. Others
15.8.6.3. Nordic
Countries Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Age Group
15.8.6.3.1. Adolescents
15.8.6.3.2. Young
Adults
15.8.6.3.3. Adults
15.8.6.3.4. Elderly
15.8.6.4. Nordic
Countries Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Drug Type
15.8.6.4.1. Illicit
Drugs
15.8.6.4.1.1. Cocaine
15.8.6.4.1.2. Crack
Cocaine
15.8.6.4.1.3. Ecstasy
15.8.6.4.1.4. Marijuana
15.8.6.4.1.5. Hallucinogens
15.8.6.4.1.6. Methamphetamine
15.8.6.4.1.7. Heroin
15.8.6.4.1.8. Others
15.8.6.4.2. Opiates/Opioids
15.8.6.4.3. Sleeping
Pills
15.8.6.4.4. Stimulants
15.8.6.4.5. Others
15.8.6.5. Nordic
Countries Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Addiction Type
15.8.6.5.1. Mild
Substance Use Disorders
15.8.6.5.2. Chronic
Substance Use Disorders
15.8.6.6. Nordic
Countries Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
15.8.6.6.1. Hospitals/Clinics
15.8.6.6.2. Rehabilitation
Centers
15.8.6.6.3. Urgent
Care Centers
15.8.6.6.4. Others
15.8.6.7. Nordic
Countries Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Country
15.8.6.7.1. Denmark
15.8.6.7.2. Finland
15.8.6.7.3. Iceland
15.8.6.7.4. Sweden
15.8.6.7.5. Norway
15.8.7. Benelux
Union
15.8.7.1. Benelux
Union Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
15.8.7.1.1. Detoxification
15.8.7.1.2. Medication
15.8.7.1.2.1. Naltrexone
15.8.7.1.2.2. Acamprosate
15.8.7.1.2.3. Disulfiram
15.8.7.1.2.4. Buprenorphine
15.8.7.1.2.5. Methadone
15.8.7.1.2.6. Others
15.8.7.1.3. Behavioral
Therapies and Counseling
15.8.7.1.3.1. Cognitive-Behavioral
Therapy (CBT)
15.8.7.1.3.2. Motivational
Enhancement Therapy (MET)
15.8.7.1.3.3. Multidimensional
Family Therapy
15.8.7.1.3.4. Dialectic
Behavioural Therapy
15.8.7.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
15.8.7.1.3.6. Therapeutic
Communities
15.8.7.1.3.7. Recovery
Housing
15.8.7.1.3.8. Self-help
Groups
15.8.7.1.3.9. Online
Counseling
15.8.7.1.3.10. Psychotherapy
15.8.7.1.3.11. Mindfulness
15.8.7.1.3.12. Specialty
Therapies
15.8.7.1.3.12.1. Music Therapy
15.8.7.1.3.12.2. Yoga Therapy
15.8.7.1.3.12.3. Animal Assisted Therapy
15.8.7.1.3.12.4. Art Therapy
15.8.7.1.3.12.5. Others
15.8.7.1.3.13. Others
15.8.7.1.4. Substance
Abuse Services
15.8.7.1.4.1. Vocational
Services
15.8.7.1.4.2. Mental
Health Services
15.8.7.1.4.3. Medical
Services
15.8.7.1.4.4. Educational
Services
15.8.7.1.4.5. HIV/AIDS
Services
15.8.7.1.4.6. Legal
Services
15.8.7.1.4.7. Family
Services
15.8.7.1.4.8. Others
15.8.7.1.5. Combination
Treatment
15.8.7.1.6. Others
15.8.7.2. Benelux
Union Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
15.8.7.2.1. Withdrawal
Symptoms
15.8.7.2.2. Relapse
Prevention
15.8.7.2.3. Co-Occurring
Conditions
15.8.7.2.3.1. Depression
15.8.7.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
15.8.7.2.3.3. Bipolar
Disorder
15.8.7.2.3.4. Schizophrenia
15.8.7.2.3.5. Others
15.8.7.2.4. Others
15.8.7.3. Benelux
Union Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
15.8.7.3.1. Adolescents
15.8.7.3.2. Young
Adults
15.8.7.3.3. Adults
15.8.7.3.4. Elderly
15.8.7.4. Benelux
Union Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug
Type
15.8.7.4.1. Illicit
Drugs
15.8.7.4.1.1. Cocaine
15.8.7.4.1.2. Crack
Cocaine
15.8.7.4.1.3. Ecstasy
15.8.7.4.1.4. Marijuana
15.8.7.4.1.5. Hallucinogens
15.8.7.4.1.6. Methamphetamine
15.8.7.4.1.7. Heroin
15.8.7.4.1.8. Others
15.8.7.4.2. Opiates/Opioids
15.8.7.4.3. Sleeping
Pills
15.8.7.4.4. Stimulants
15.8.7.4.5. Others
15.8.7.5. Benelux
Union Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Addiction Type
15.8.7.5.1. Mild
Substance Use Disorders
15.8.7.5.2. Chronic
Substance Use Disorders
15.8.7.6. Benelux
Union Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
15.8.7.6.1. Hospitals/Clinics
15.8.7.6.2. Rehabilitation
Centers
15.8.7.6.3. Urgent
Care Centers
15.8.7.6.4. Others
15.8.7.7. Benelux
Union Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Country
15.8.7.7.1. Belgium
15.8.7.7.2. The
Netherlands
15.8.7.7.3. Luxembourg
15.8.8. Rest of
Europe
15.8.8.1. Rest
of Europe Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
15.8.8.1.1. Detoxification
15.8.8.1.2. Medication
15.8.8.1.2.1. Naltrexone
15.8.8.1.2.2. Acamprosate
15.8.8.1.2.3. Disulfiram
15.8.8.1.2.4. Buprenorphine
15.8.8.1.2.5. Methadone
15.8.8.1.2.6. Others
15.8.8.1.3. Behavioral
Therapies and Counseling
15.8.8.1.3.1. Cognitive-Behavioral
Therapy (CBT)
15.8.8.1.3.2. Motivational
Enhancement Therapy (MET)
15.8.8.1.3.3. Multidimensional
Family Therapy
15.8.8.1.3.4. Dialectic
Behavioural Therapy
15.8.8.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
15.8.8.1.3.6. Therapeutic
Communities
15.8.8.1.3.7. Recovery
Housing
15.8.8.1.3.8. Self-help
Groups
15.8.8.1.3.9. Online
Counseling
15.8.8.1.3.10. Psychotherapy
15.8.8.1.3.11. Mindfulness
15.8.8.1.3.12. Specialty
Therapies
15.8.8.1.3.12.1. Music Therapy
15.8.8.1.3.12.2. Yoga Therapy
15.8.8.1.3.12.3. Animal Assisted Therapy
15.8.8.1.3.12.4. Art Therapy
15.8.8.1.3.12.5. Others
15.8.8.1.3.13. Others
15.8.8.1.4. Substance
Abuse Services
15.8.8.1.4.1. Vocational
Services
15.8.8.1.4.2. Mental
Health Services
15.8.8.1.4.3. Medical
Services
15.8.8.1.4.4. Educational
Services
15.8.8.1.4.5. HIV/AIDS
Services
15.8.8.1.4.6. Legal
Services
15.8.8.1.4.7. Family
Services
15.8.8.1.4.8. Others
15.8.8.1.5. Combination
Treatment
15.8.8.1.6. Others
15.8.8.2. Rest
of Europe Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
15.8.8.2.1. Withdrawal
Symptoms
15.8.8.2.2. Relapse
Prevention
15.8.8.2.3. Co-Occurring
Conditions
15.8.8.2.3.1. Depression
15.8.8.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
15.8.8.2.3.3. Bipolar
Disorder
15.8.8.2.3.4. Schizophrenia
15.8.8.2.3.5. Others
15.8.8.2.4. Others
15.8.8.3. Rest
of Europe Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Age Group
15.8.8.3.1. Adolescents
15.8.8.3.2. Young
Adults
15.8.8.3.3. Adults
15.8.8.3.4. Elderly
15.8.8.4. Rest
of Europe Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Drug Type
15.8.8.4.1. Illicit
Drugs
15.8.8.4.1.1. Cocaine
15.8.8.4.1.2. Crack
Cocaine
15.8.8.4.1.3. Ecstasy
15.8.8.4.1.4. Marijuana
15.8.8.4.1.5. Hallucinogens
15.8.8.4.1.6. Methamphetamine
15.8.8.4.1.7. Heroin
15.8.8.4.1.8. Others
15.8.8.4.2. Opiates/Opioids
15.8.8.4.3. Sleeping
Pills
15.8.8.4.4. Stimulants
15.8.8.4.5. Others
15.8.8.5. Rest
of Europe Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Addiction Type
15.8.8.5.1. Mild
Substance Use Disorders
15.8.8.5.2. Chronic
Substance Use Disorders
15.8.8.6. Rest
of Europe Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
15.8.8.6.1. Hospitals/Clinics
15.8.8.6.2. Rehabilitation
Centers
15.8.8.6.3. Urgent
Care Centers
15.8.8.6.4. Others
15.9. Key
Segment for Channeling Investments
15.9.1. By
Country
15.9.2. By
Treatment Type
15.9.3. By
Application
15.9.4. By Age
Group
15.9.5. By Drug
Type
15.9.6. By
Addiction Type
15.9.7. By
Providers
16. Asia
Pacific Drug Addiction Treatment Market Analysis and Forecasts, 2019 - 2027
16.1. Overview
16.1.1. Asia
Pacific Drug Addiction Treatment Market Revenue (US$ Mn)
16.2. Asia
Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
16.2.1. Detoxification
16.2.2. Medication
16.2.2.1. Naltrexone
16.2.2.2. Acamprosate
16.2.2.3. Disulfiram
16.2.2.4. Buprenorphine
16.2.2.5. Methadone
16.2.2.6. Others
16.2.3. Behavioral
Therapies and Counseling
16.2.3.1. Cognitive-Behavioral
Therapy (CBT)
16.2.3.2. Motivational
Enhancement Therapy (MET)
16.2.3.3. Multidimensional
Family Therapy
16.2.3.4. Dialectic
Behavioural Therapy
16.2.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
16.2.3.6. Therapeutic
Communities
16.2.3.7. Recovery
Housing
16.2.3.8. Self-help
Groups
16.2.3.9. Online
Counseling
16.2.3.10. Psychotherapy
16.2.3.11. Mindfulness
16.2.3.12. Specialty
Therapies
16.2.3.12.1. Music
Therapy
16.2.3.12.2. Yoga
Therapy
16.2.3.12.3. Animal
Assisted Therapy
16.2.3.12.4. Art
Therapy
16.2.3.12.5. Others
16.2.3.13. Others
16.2.4. Substance
Abuse Services
16.2.4.1. Vocational
Services
16.2.4.2. Mental
Health Services
16.2.4.3. Medical
Services
16.2.4.4. Educational
Services
16.2.4.5. HIV/AIDS
Services
16.2.4.6. Legal
Services
16.2.4.7. Family
Services
16.2.4.8. Others
16.2.5. Combination
Treatment
16.2.6. Others
16.3. Asia
Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
16.3.1. Withdrawal
Symptoms
16.3.2. Relapse
Prevention
16.3.3. Co-Occurring
Conditions
16.3.3.1. Depression
16.3.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
16.3.3.3. Bipolar
Disorder
16.3.3.4. Schizophrenia
16.3.3.5. Others
16.3.4. Others
16.4. Asia
Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
16.4.1. Adolescents
16.4.2. Young
Adults
16.4.3. Adults
16.4.4. Elderly
16.5. Asia
Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug
Type
16.5.1. Illicit
Drugs
16.5.1.1. Cocaine
16.5.1.2. Crack
Cocaine
16.5.1.3. Ecstasy
16.5.1.4. Marijuana
16.5.1.5. Hallucinogens
16.5.1.6. Methamphetamine
16.5.1.7. Heroin
16.5.1.8. Others
16.5.2. Opiates/Opioids
16.5.3. Sleeping
Pills
16.5.4. Stimulants
16.5.5. Others
16.6. Asia
Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Addiction Type
16.6.1. Mild
Substance Use Disorders
16.6.2. Chronic
Substance Use Disorders
16.7. Asia
Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
16.7.1. Hospitals/Clinics
16.7.2. Rehabilitation
Centers
16.7.3. Urgent
Care Centers
16.7.4. Others
16.8. Asia
Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Country
16.8.1. China
16.8.1.1. China
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
16.8.1.1.1. Detoxification
16.8.1.1.2. Medication
16.8.1.1.2.1. Naltrexone
16.8.1.1.2.2. Acamprosate
16.8.1.1.2.3. Disulfiram
16.8.1.1.2.4. Buprenorphine
16.8.1.1.2.5. Methadone
16.8.1.1.2.6. Others
16.8.1.1.3. Behavioral
Therapies and Counseling
16.8.1.1.3.1. Cognitive-Behavioral
Therapy (CBT)
16.8.1.1.3.2. Motivational
Enhancement Therapy (MET)
16.8.1.1.3.3. Multidimensional
Family Therapy
16.8.1.1.3.4. Dialectic
Behavioural Therapy
16.8.1.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
16.8.1.1.3.6. Therapeutic
Communities
16.8.1.1.3.7. Recovery
Housing
16.8.1.1.3.8. Self-help
Groups
16.8.1.1.3.9. Online
Counseling
16.8.1.1.3.10. Psychotherapy
16.8.1.1.3.11. Mindfulness
16.8.1.1.3.12. Specialty
Therapies
16.8.1.1.3.12.1. Music Therapy
16.8.1.1.3.12.2. Yoga Therapy
16.8.1.1.3.12.3. Animal Assisted Therapy
16.8.1.1.3.12.4. Art Therapy
16.8.1.1.3.12.5. Others
16.8.1.1.3.13. Others
16.8.1.1.4. Substance
Abuse Services
16.8.1.1.4.1. Vocational
Services
16.8.1.1.4.2. Mental
Health Services
16.8.1.1.4.3. Medical
Services
16.8.1.1.4.4. Educational
Services
16.8.1.1.4.5. HIV/AIDS
Services
16.8.1.1.4.6. Legal
Services
16.8.1.1.4.7. Family
Services
16.8.1.1.4.8. Others
16.8.1.1.5. Combination
Treatment
16.8.1.1.6. Others
16.8.1.2. China
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
16.8.1.2.1. Withdrawal
Symptoms
16.8.1.2.2. Relapse
Prevention
16.8.1.2.3. Co-Occurring
Conditions
16.8.1.2.3.1. Depression
16.8.1.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
16.8.1.2.3.3. Bipolar
Disorder
16.8.1.2.3.4. Schizophrenia
16.8.1.2.3.5. Others
16.8.1.2.4. Others
16.8.1.3. China
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.1.3.1. Adolescents
16.8.1.3.2. Young
Adults
16.8.1.3.3. Adults
16.8.1.3.4. Elderly
16.8.1.4. China
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
16.8.1.4.1. Illicit
Drugs
16.8.1.4.1.1. Cocaine
16.8.1.4.1.2. Crack
Cocaine
16.8.1.4.1.3. Ecstasy
16.8.1.4.1.4. Marijuana
16.8.1.4.1.5. Hallucinogens
16.8.1.4.1.6. Methamphetamine
16.8.1.4.1.7. Heroin
16.8.1.4.1.8. Others
16.8.1.4.2. Opiates/Opioids
16.8.1.4.3. Sleeping
Pills
16.8.1.4.4. Stimulants
16.8.1.4.5. Others
16.8.1.5. China
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
16.8.1.5.1. Mild
Substance Use Disorders
16.8.1.5.2. Chronic
Substance Use Disorders
16.8.1.6. China
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
16.8.1.6.1. Hospitals/Clinics
16.8.1.6.2. Rehabilitation
Centers
16.8.1.6.3. Urgent
Care Centers
16.8.1.6.4. Others
16.8.2. Japan
16.8.2.1. Japan
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
16.8.2.1.1. Detoxification
16.8.2.1.2. Medication
16.8.2.1.2.1. Naltrexone
16.8.2.1.2.2. Acamprosate
16.8.2.1.2.3. Disulfiram
16.8.2.1.2.4. Buprenorphine
16.8.2.1.2.5. Methadone
16.8.2.1.2.6. Others
16.8.2.1.3. Behavioral
Therapies and Counseling
16.8.2.1.3.1. Cognitive-Behavioral
Therapy (CBT)
16.8.2.1.3.2. Motivational
Enhancement Therapy (MET)
16.8.2.1.3.3. Multidimensional
Family Therapy
16.8.2.1.3.4. Dialectic
Behavioural Therapy
16.8.2.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
16.8.2.1.3.6. Therapeutic
Communities
16.8.2.1.3.7. Recovery
Housing
16.8.2.1.3.8. Self-help
Groups
16.8.2.1.3.9. Online
Counseling
16.8.2.1.3.10. Psychotherapy
16.8.2.1.3.11. Mindfulness
16.8.2.1.3.12. Specialty
Therapies
16.8.2.1.3.12.1. Music Therapy
16.8.2.1.3.12.2. Yoga Therapy
16.8.2.1.3.12.3. Animal Assisted Therapy
16.8.2.1.3.12.4. Art Therapy
16.8.2.1.3.12.5. Others
16.8.2.1.3.13. Others
16.8.2.1.4. Substance
Abuse Services
16.8.2.1.4.1. Vocational
Services
16.8.2.1.4.2. Mental
Health Services
16.8.2.1.4.3. Medical
Services
16.8.2.1.4.4. Educational
Services
16.8.2.1.4.5. HIV/AIDS
Services
16.8.2.1.4.6. Legal
Services
16.8.2.1.4.7. Family
Services
16.8.2.1.4.8. Others
16.8.2.1.5. Combination
Treatment
16.8.2.1.6. Others
16.8.2.2. Japan
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
16.8.2.2.1. Withdrawal
Symptoms
16.8.2.2.2. Relapse
Prevention
16.8.2.2.3. Co-Occurring
Conditions
16.8.2.2.3.1. Depression
16.8.2.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
16.8.2.2.3.3. Bipolar
Disorder
16.8.2.2.3.4. Schizophrenia
16.8.2.2.3.5. Others
16.8.2.2.4. Others
16.8.2.3. Japan
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.2.3.1. Adolescents
16.8.2.3.2. Young
Adults
16.8.2.3.3. Adults
16.8.2.3.4. Elderly
16.8.2.4. Japan
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
16.8.2.4.1. Illicit
Drugs
16.8.2.4.1.1. Cocaine
16.8.2.4.1.2. Crack
Cocaine
16.8.2.4.1.3. Ecstasy
16.8.2.4.1.4. Marijuana
16.8.2.4.1.5. Hallucinogens
16.8.2.4.1.6. Methamphetamine
16.8.2.4.1.7. Heroin
16.8.2.4.1.8. Others
16.8.2.4.2. Opiates/Opioids
16.8.2.4.3. Sleeping
Pills
16.8.2.4.4. Stimulants
16.8.2.4.5. Others
16.8.2.5. Japan
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
16.8.2.5.1. Mild
Substance Use Disorders
16.8.2.5.2. Chronic
Substance Use Disorders
16.8.2.6. Japan
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
16.8.2.6.1. Hospitals/Clinics
16.8.2.6.2. Rehabilitation
Centers
16.8.2.6.3. Urgent
Care Centers
16.8.2.6.4. Others
16.8.3. India
16.8.3.1. India
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
16.8.3.1.1. Detoxification
16.8.3.1.2. Medication
16.8.3.1.2.1. Naltrexone
16.8.3.1.2.2. Acamprosate
16.8.3.1.2.3. Disulfiram
16.8.3.1.2.4. Buprenorphine
16.8.3.1.2.5. Methadone
16.8.3.1.2.6. Others
16.8.3.1.3. Behavioral
Therapies and Counseling
16.8.3.1.3.1. Cognitive-Behavioral
Therapy (CBT)
16.8.3.1.3.2. Motivational
Enhancement Therapy (MET)
16.8.3.1.3.3. Multidimensional
Family Therapy
16.8.3.1.3.4. Dialectic
Behavioural Therapy
16.8.3.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
16.8.3.1.3.6. Therapeutic
Communities
16.8.3.1.3.7. Recovery
Housing
16.8.3.1.3.8. Self-help
Groups
16.8.3.1.3.9. Online
Counseling
16.8.3.1.3.10. Psychotherapy
16.8.3.1.3.11. Mindfulness
16.8.3.1.3.12. Specialty
Therapies
16.8.3.1.3.12.1. Music Therapy
16.8.3.1.3.12.2. Yoga Therapy
16.8.3.1.3.12.3. Animal Assisted Therapy
16.8.3.1.3.12.4. Art Therapy
16.8.3.1.3.12.5. Others
16.8.3.1.3.13. Others
16.8.3.1.4. Substance
Abuse Services
16.8.3.1.4.1. Vocational
Services
16.8.3.1.4.2. Mental
Health Services
16.8.3.1.4.3. Medical
Services
16.8.3.1.4.4. Educational
Services
16.8.3.1.4.5. HIV/AIDS
Services
16.8.3.1.4.6. Legal
Services
16.8.3.1.4.7. Family
Services
16.8.3.1.4.8. Others
16.8.3.1.5. Combination
Treatment
16.8.3.1.6. Others
16.8.3.2. India
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
16.8.3.2.1. Withdrawal
Symptoms
16.8.3.2.2. Relapse
Prevention
16.8.3.2.3. Co-Occurring
Conditions
16.8.3.2.3.1. Depression
16.8.3.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
16.8.3.2.3.3. Bipolar
Disorder
16.8.3.2.3.4. Schizophrenia
16.8.3.2.3.5. Others
16.8.3.2.4. Others
16.8.3.3. India
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.3.3.1. Adolescents
16.8.3.3.2. Young
Adults
16.8.3.3.3. Adults
16.8.3.3.4. Elderly
16.8.3.4. India
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
16.8.3.4.1. Illicit
Drugs
16.8.3.4.1.1. Cocaine
16.8.3.4.1.2. Crack
Cocaine
16.8.3.4.1.3. Ecstasy
16.8.3.4.1.4. Marijuana
16.8.3.4.1.5. Hallucinogens
16.8.3.4.1.6. Methamphetamine
16.8.3.4.1.7. Heroin
16.8.3.4.1.8. Others
16.8.3.4.2. Opiates/Opioids
16.8.3.4.3. Sleeping
Pills
16.8.3.4.4. Stimulants
16.8.3.4.5. Others
16.8.3.5. India
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
16.8.3.5.1. Mild
Substance Use Disorders
16.8.3.5.2. Chronic
Substance Use Disorders
16.8.3.6. India
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
16.8.3.6.1. Hospitals/Clinics
16.8.3.6.2. Rehabilitation
Centers
16.8.3.6.3. Urgent
Care Centers
16.8.3.6.4. Others
16.8.4. New
Zealand
16.8.4.1. New
Zealand Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
16.8.4.1.1. Detoxification
16.8.4.1.2. Medication
16.8.4.1.2.1. Naltrexone
16.8.4.1.2.2. Acamprosate
16.8.4.1.2.3. Disulfiram
16.8.4.1.2.4. Buprenorphine
16.8.4.1.2.5. Methadone
16.8.4.1.2.6. Others
16.8.4.1.3. Behavioral
Therapies and Counseling
16.8.4.1.3.1. Cognitive-Behavioral
Therapy (CBT)
16.8.4.1.3.2. Motivational
Enhancement Therapy (MET)
16.8.4.1.3.3. Multidimensional
Family Therapy
16.8.4.1.3.4. Dialectic
Behavioural Therapy
16.8.4.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
16.8.4.1.3.6. Therapeutic
Communities
16.8.4.1.3.7. Recovery
Housing
16.8.4.1.3.8. Self-help
Groups
16.8.4.1.3.9. Online
Counseling
16.8.4.1.3.10. Psychotherapy
16.8.4.1.3.11. Mindfulness
16.8.4.1.3.12. Specialty
Therapies
16.8.4.1.3.12.1. Music Therapy
16.8.4.1.3.12.2. Yoga Therapy
16.8.4.1.3.12.3. Animal Assisted Therapy
16.8.4.1.3.12.4. Art Therapy
16.8.4.1.3.12.5. Others
16.8.4.1.3.13. Others
16.8.4.1.4. Substance
Abuse Services
16.8.4.1.4.1. Vocational
Services
16.8.4.1.4.2. Mental
Health Services
16.8.4.1.4.3. Medical
Services
16.8.4.1.4.4. Educational
Services
16.8.4.1.4.5. HIV/AIDS
Services
16.8.4.1.4.6. Legal
Services
16.8.4.1.4.7. Family
Services
16.8.4.1.4.8. Others
16.8.4.1.5. Combination
Treatment
16.8.4.1.6. Others
16.8.4.2. New
Zealand Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
16.8.4.2.1. Withdrawal
Symptoms
16.8.4.2.2. Relapse
Prevention
16.8.4.2.3. Co-Occurring
Conditions
16.8.4.2.3.1. Depression
16.8.4.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
16.8.4.2.3.3. Bipolar
Disorder
16.8.4.2.3.4. Schizophrenia
16.8.4.2.3.5. Others
16.8.4.2.4. Others
16.8.4.3. New
Zealand Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
16.8.4.3.1. Adolescents
16.8.4.3.2. Young
Adults
16.8.4.3.3. Adults
16.8.4.3.4. Elderly
16.8.4.4. New
Zealand Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug
Type
16.8.4.4.1. Illicit
Drugs
16.8.4.4.1.1. Cocaine
16.8.4.4.1.2. Crack
Cocaine
16.8.4.4.1.3. Ecstasy
16.8.4.4.1.4. Marijuana
16.8.4.4.1.5. Hallucinogens
16.8.4.4.1.6. Methamphetamine
16.8.4.4.1.7. Heroin
16.8.4.4.1.8. Others
16.8.4.4.2. Opiates/Opioids
16.8.4.4.3. Sleeping
Pills
16.8.4.4.4. Stimulants
16.8.4.4.5. Others
16.8.4.5. New
Zealand Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Addiction Type
16.8.4.5.1. Mild
Substance Use Disorders
16.8.4.5.2. Chronic
Substance Use Disorders
16.8.4.6. New
Zealand Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
16.8.4.6.1. Hospitals/Clinics
16.8.4.6.2. Rehabilitation
Centers
16.8.4.6.3. Urgent
Care Centers
16.8.4.6.4. Others
16.8.5. Australia
16.8.5.1. Australia
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
16.8.5.1.1. Detoxification
16.8.5.1.2. Medication
16.8.5.1.2.1. Naltrexone
16.8.5.1.2.2. Acamprosate
16.8.5.1.2.3. Disulfiram
16.8.5.1.2.4. Buprenorphine
16.8.5.1.2.5. Methadone
16.8.5.1.2.6. Others
16.8.5.1.3. Behavioral
Therapies and Counseling
16.8.5.1.3.1. Cognitive-Behavioral
Therapy (CBT)
16.8.5.1.3.2. Motivational
Enhancement Therapy (MET)
16.8.5.1.3.3. Multidimensional
Family Therapy
16.8.5.1.3.4. Dialectic
Behavioural Therapy
16.8.5.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
16.8.5.1.3.6. Therapeutic
Communities
16.8.5.1.3.7. Recovery
Housing
16.8.5.1.3.8. Self-help
Groups
16.8.5.1.3.9. Online
Counseling
16.8.5.1.3.10. Psychotherapy
16.8.5.1.3.11. Mindfulness
16.8.5.1.3.12. Specialty
Therapies
16.8.5.1.3.12.1. Music Therapy
16.8.5.1.3.12.2. Yoga Therapy
16.8.5.1.3.12.3. Animal Assisted Therapy
16.8.5.1.3.12.4. Art Therapy
16.8.5.1.3.12.5. Others
16.8.5.1.3.13. Others
16.8.5.1.4. Substance
Abuse Services
16.8.5.1.4.1. Vocational
Services
16.8.5.1.4.2. Mental
Health Services
16.8.5.1.4.3. Medical
Services
16.8.5.1.4.4. Educational
Services
16.8.5.1.4.5. HIV/AIDS
Services
16.8.5.1.4.6. Legal
Services
16.8.5.1.4.7. Family
Services
16.8.5.1.4.8. Others
16.8.5.1.5. Combination
Treatment
16.8.5.1.6. Others
16.8.5.2. Australia
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
16.8.5.2.1. Withdrawal
Symptoms
16.8.5.2.2. Relapse
Prevention
16.8.5.2.3. Co-Occurring
Conditions
16.8.5.2.3.1. Depression
16.8.5.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
16.8.5.2.3.3. Bipolar
Disorder
16.8.5.2.3.4. Schizophrenia
16.8.5.2.3.5. Others
16.8.5.2.4. Others
16.8.5.3. Australia
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.5.3.1. Adolescents
16.8.5.3.2. Young
Adults
16.8.5.3.3. Adults
16.8.5.3.4. Elderly
16.8.5.4. Australia
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
16.8.5.4.1. Illicit
Drugs
16.8.5.4.1.1. Cocaine
16.8.5.4.1.2. Crack
Cocaine
16.8.5.4.1.3. Ecstasy
16.8.5.4.1.4. Marijuana
16.8.5.4.1.5. Hallucinogens
16.8.5.4.1.6. Methamphetamine
16.8.5.4.1.7. Heroin
16.8.5.4.1.8. Others
16.8.5.4.2. Opiates/Opioids
16.8.5.4.3. Sleeping
Pills
16.8.5.4.4. Stimulants
16.8.5.4.5. Others
16.8.5.5. Australia
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
16.8.5.5.1. Mild
Substance Use Disorders
16.8.5.5.2. Chronic
Substance Use Disorders
16.8.5.6. Australia
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
16.8.5.6.1. Hospitals/Clinics
16.8.5.6.2. Rehabilitation
Centers
16.8.5.6.3. Urgent
Care Centers
16.8.5.6.4. Others
16.8.6. South
Korea
16.8.6.1. South
Korea Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
16.8.6.1.1. Detoxification
16.8.6.1.2. Medication
16.8.6.1.2.1. Naltrexone
16.8.6.1.2.2. Acamprosate
16.8.6.1.2.3. Disulfiram
16.8.6.1.2.4. Buprenorphine
16.8.6.1.2.5. Methadone
16.8.6.1.2.6. Others
16.8.6.1.3. Behavioral
Therapies and Counseling
16.8.6.1.3.1. Cognitive-Behavioral
Therapy (CBT)
16.8.6.1.3.2. Motivational
Enhancement Therapy (MET)
16.8.6.1.3.3. Multidimensional
Family Therapy
16.8.6.1.3.4. Dialectic
Behavioural Therapy
16.8.6.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
16.8.6.1.3.6. Therapeutic
Communities
16.8.6.1.3.7. Recovery
Housing
16.8.6.1.3.8. Self-help
Groups
16.8.6.1.3.9. Online
Counseling
16.8.6.1.3.10. Psychotherapy
16.8.6.1.3.11. Mindfulness
16.8.6.1.3.12. Specialty
Therapies
16.8.6.1.3.12.1. Music Therapy
16.8.6.1.3.12.2. Yoga Therapy
16.8.6.1.3.12.3. Animal Assisted Therapy
16.8.6.1.3.12.4. Art Therapy
16.8.6.1.3.12.5. Others
16.8.6.1.3.13. Others
16.8.6.1.4. Substance
Abuse Services
16.8.6.1.4.1. Vocational
Services
16.8.6.1.4.2. Mental
Health Services
16.8.6.1.4.3. Medical
Services
16.8.6.1.4.4. Educational
Services
16.8.6.1.4.5. HIV/AIDS
Services
16.8.6.1.4.6. Legal
Services
16.8.6.1.4.7. Family
Services
16.8.6.1.4.8. Others
16.8.6.1.5. Combination
Treatment
16.8.6.1.6. Others
16.8.6.2. South
Korea Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
16.8.6.2.1. Withdrawal
Symptoms
16.8.6.2.2. Relapse
Prevention
16.8.6.2.3. Co-Occurring
Conditions
16.8.6.2.3.1. Depression
16.8.6.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
16.8.6.2.3.3. Bipolar
Disorder
16.8.6.2.3.4. Schizophrenia
16.8.6.2.3.5. Others
16.8.6.2.4. Others
16.8.6.3. South
Korea Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
16.8.6.3.1. Adolescents
16.8.6.3.2. Young
Adults
16.8.6.3.3. Adults
16.8.6.3.4. Elderly
16.8.6.4. South
Korea Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug
Type
16.8.6.4.1. Illicit
Drugs
16.8.6.4.1.1. Cocaine
16.8.6.4.1.2. Crack
Cocaine
16.8.6.4.1.3. Ecstasy
16.8.6.4.1.4. Marijuana
16.8.6.4.1.5. Hallucinogens
16.8.6.4.1.6. Methamphetamine
16.8.6.4.1.7. Heroin
16.8.6.4.1.8. Others
16.8.6.4.2. Opiates/Opioids
16.8.6.4.3. Sleeping
Pills
16.8.6.4.4. Stimulants
16.8.6.4.5. Others
16.8.6.5. South
Korea Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Addiction Type
16.8.6.5.1. Mild
Substance Use Disorders
16.8.6.5.2. Chronic
Substance Use Disorders
16.8.6.6. South
Korea Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
16.8.6.6.1. Hospitals/Clinics
16.8.6.6.2. Rehabilitation
Centers
16.8.6.6.3. Urgent
Care Centers
16.8.6.6.4. Others
16.8.7. Southeast
Asia
16.8.7.1. Southeast
Asia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
16.8.7.1.1. Detoxification
16.8.7.1.2. Medication
16.8.7.1.2.1. Naltrexone
16.8.7.1.2.2. Acamprosate
16.8.7.1.2.3. Disulfiram
16.8.7.1.2.4. Buprenorphine
16.8.7.1.2.5. Methadone
16.8.7.1.2.6. Others
16.8.7.1.3. Behavioral
Therapies and Counseling
16.8.7.1.3.1. Cognitive-Behavioral
Therapy (CBT)
16.8.7.1.3.2. Motivational
Enhancement Therapy (MET)
16.8.7.1.3.3. Multidimensional
Family Therapy
16.8.7.1.3.4. Dialectic
Behavioural Therapy
16.8.7.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
16.8.7.1.3.6. Therapeutic
Communities
16.8.7.1.3.7. Recovery
Housing
16.8.7.1.3.8. Self-help
Groups
16.8.7.1.3.9. Online
Counseling
16.8.7.1.3.10. Psychotherapy
16.8.7.1.3.11. Mindfulness
16.8.7.1.3.12. Specialty
Therapies
16.8.7.1.3.12.1. Music Therapy
16.8.7.1.3.12.2. Yoga Therapy
16.8.7.1.3.12.3. Animal Assisted Therapy
16.8.7.1.3.12.4. Art Therapy
16.8.7.1.3.12.5. Others
16.8.7.1.3.13. Others
16.8.7.1.4. Substance
Abuse Services
16.8.7.1.4.1. Vocational
Services
16.8.7.1.4.2. Mental
Health Services
16.8.7.1.4.3. Medical
Services
16.8.7.1.4.4. Educational
Services
16.8.7.1.4.5. HIV/AIDS
Services
16.8.7.1.4.6. Legal
Services
16.8.7.1.4.7. Family
Services
16.8.7.1.4.8. Others
16.8.7.1.5. Combination
Treatment
16.8.7.1.6. Others
16.8.7.2. Southeast
Asia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
16.8.7.2.1. Withdrawal
Symptoms
16.8.7.2.2. Relapse
Prevention
16.8.7.2.3. Co-Occurring
Conditions
16.8.7.2.3.1. Depression
16.8.7.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
16.8.7.2.3.3. Bipolar
Disorder
16.8.7.2.3.4. Schizophrenia
16.8.7.2.3.5. Others
16.8.7.2.4. Others
16.8.7.3. Southeast
Asia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
16.8.7.3.1. Adolescents
16.8.7.3.2. Young
Adults
16.8.7.3.3. Adults
16.8.7.3.4. Elderly
16.8.7.4. Southeast
Asia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug
Type
16.8.7.4.1. Illicit
Drugs
16.8.7.4.1.1. Cocaine
16.8.7.4.1.2. Crack
Cocaine
16.8.7.4.1.3. Ecstasy
16.8.7.4.1.4. Marijuana
16.8.7.4.1.5. Hallucinogens
16.8.7.4.1.6. Methamphetamine
16.8.7.4.1.7. Heroin
16.8.7.4.1.8. Others
16.8.7.4.2. Opiates/Opioids
16.8.7.4.3. Sleeping
Pills
16.8.7.4.4. Stimulants
16.8.7.4.5. Others
16.8.7.5. Southeast
Asia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
16.8.7.5.1. Mild
Substance Use Disorders
16.8.7.5.2. Chronic
Substance Use Disorders
16.8.7.6. Southeast
Asia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
16.8.7.6.1. Hospitals/Clinics
16.8.7.6.2. Rehabilitation
Centers
16.8.7.6.3. Urgent
Care Centers
16.8.7.6.4. Others
16.8.7.7. Southeast
Asia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Country
16.8.7.7.1. Indonesia
16.8.7.7.2. Thailand
16.8.7.7.3. Malaysia
16.8.7.7.4. Singapore
16.8.7.7.5. Rest
of Southeast Asia
16.8.8. Rest of
Asia Pacific
16.8.8.1. Rest
of Asia Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Treatment Type
16.8.8.1.1. Detoxification
16.8.8.1.2. Medication
16.8.8.1.2.1. Naltrexone
16.8.8.1.2.2. Acamprosate
16.8.8.1.2.3. Disulfiram
16.8.8.1.2.4. Buprenorphine
16.8.8.1.2.5. Methadone
16.8.8.1.2.6. Others
16.8.8.1.3. Behavioral
Therapies and Counseling
16.8.8.1.3.1. Cognitive-Behavioral
Therapy (CBT)
16.8.8.1.3.2. Motivational
Enhancement Therapy (MET)
16.8.8.1.3.3. Multidimensional
Family Therapy
16.8.8.1.3.4. Dialectic
Behavioural Therapy
16.8.8.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
16.8.8.1.3.6. Therapeutic
Communities
16.8.8.1.3.7. Recovery
Housing
16.8.8.1.3.8. Self-help
Groups
16.8.8.1.3.9. Online
Counseling
16.8.8.1.3.10. Psychotherapy
16.8.8.1.3.11. Mindfulness
16.8.8.1.3.12. Specialty
Therapies
16.8.8.1.3.12.1. Music Therapy
16.8.8.1.3.12.2. Yoga Therapy
16.8.8.1.3.12.3. Animal Assisted Therapy
16.8.8.1.3.12.4. Art Therapy
16.8.8.1.3.12.5. Others
16.8.8.1.3.13. Others
16.8.8.1.4. Substance
Abuse Services
16.8.8.1.4.1. Vocational
Services
16.8.8.1.4.2. Mental
Health Services
16.8.8.1.4.3. Medical
Services
16.8.8.1.4.4. Educational
Services
16.8.8.1.4.5. HIV/AIDS
Services
16.8.8.1.4.6. Legal
Services
16.8.8.1.4.7. Family
Services
16.8.8.1.4.8. Others
16.8.8.1.5. Combination
Treatment
16.8.8.1.6. Others
16.8.8.2. Rest
of Asia Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Application
16.8.8.2.1. Withdrawal
Symptoms
16.8.8.2.2. Relapse
Prevention
16.8.8.2.3. Co-Occurring
Conditions
16.8.8.2.3.1. Depression
16.8.8.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
16.8.8.2.3.3. Bipolar
Disorder
16.8.8.2.3.4. Schizophrenia
16.8.8.2.3.5. Others
16.8.8.2.4. Others
16.8.8.3. Rest
of Asia Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Age Group
16.8.8.3.1. Adolescents
16.8.8.3.2. Young
Adults
16.8.8.3.3. Adults
16.8.8.3.4. Elderly
16.8.8.4. Rest
of Asia Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Drug Type
16.8.8.4.1. Illicit
Drugs
16.8.8.4.1.1. Cocaine
16.8.8.4.1.2. Crack
Cocaine
16.8.8.4.1.3. Ecstasy
16.8.8.4.1.4. Marijuana
16.8.8.4.1.5. Hallucinogens
16.8.8.4.1.6. Methamphetamine
16.8.8.4.1.7. Heroin
16.8.8.4.1.8. Others
16.8.8.4.2. Opiates/Opioids
16.8.8.4.3. Sleeping
Pills
16.8.8.4.4. Stimulants
16.8.8.4.5. Others
16.8.8.5. Rest
of Asia Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Addiction Type
16.8.8.5.1. Mild
Substance Use Disorders
16.8.8.5.2. Chronic
Substance Use Disorders
16.8.8.6. Rest
of Asia Pacific Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Providers
16.8.8.6.1. Hospitals/Clinics
16.8.8.6.2. Rehabilitation
Centers
16.8.8.6.3. Urgent
Care Centers
16.8.8.6.4. Others
16.9. Key
Segment for Channeling Investments
16.9.1. By
Country
16.9.2. By
Treatment Type
16.9.3. By
Application
16.9.4. By Age
Group
16.9.5. By Drug
Type
16.9.6. By
Addiction Type
16.9.7. By
Providers
17. Middle
East and Africa Drug Addiction Treatment Market Analysis and Forecasts, 2019 -
2027
17.1. Overview
17.1.1. Middle
East and Africa Drug Addiction Treatment Market Revenue (US$ Mn)
17.2. Middle
East and Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Treatment Type
17.2.1. Detoxification
17.2.2. Medication
17.2.2.1. Naltrexone
17.2.2.2. Acamprosate
17.2.2.3. Disulfiram
17.2.2.4. Buprenorphine
17.2.2.5. Methadone
17.2.2.6. Others
17.2.3. Behavioral
Therapies and Counseling
17.2.3.1. Cognitive-Behavioral
Therapy (CBT)
17.2.3.2. Motivational
Enhancement Therapy (MET)
17.2.3.3. Multidimensional
Family Therapy
17.2.3.4. Dialectic
Behavioural Therapy
17.2.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
17.2.3.6. Therapeutic
Communities
17.2.3.7. Recovery
Housing
17.2.3.8. Self-help
Groups
17.2.3.9. Online
Counseling
17.2.3.10. Psychotherapy
17.2.3.11. Mindfulness
17.2.3.12. Specialty
Therapies
17.2.3.12.1. Music
Therapy
17.2.3.12.2. Yoga
Therapy
17.2.3.12.3. Animal
Assisted Therapy
17.2.3.12.4. Art
Therapy
17.2.3.12.5. Others
17.2.3.13. Others
17.2.4. Substance
Abuse Services
17.2.4.1. Vocational
Services
17.2.4.2. Mental
Health Services
17.2.4.3. Medical
Services
17.2.4.4. Educational
Services
17.2.4.5. HIV/AIDS
Services
17.2.4.6. Legal
Services
17.2.4.7. Family
Services
17.2.4.8. Others
17.2.5. Combination
Treatment
17.2.6. Others
17.3. Middle
East and Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Application
17.3.1. Withdrawal
Symptoms
17.3.2. Relapse
Prevention
17.3.3. Co-Occurring
Conditions
17.3.3.1. Depression
17.3.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
17.3.3.3. Bipolar
Disorder
17.3.3.4. Schizophrenia
17.3.3.5. Others
17.3.4. Others
17.4. Middle
East and Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Age Group
17.4.1. Adolescents
17.4.2. Young
Adults
17.4.3. Adults
17.4.4. Elderly
17.5. Middle
East and Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Drug Type
17.5.1. Illicit
Drugs
17.5.1.1. Cocaine
17.5.1.2. Crack
Cocaine
17.5.1.3. Ecstasy
17.5.1.4. Marijuana
17.5.1.5. Hallucinogens
17.5.1.6. Methamphetamine
17.5.1.7. Heroin
17.5.1.8. Others
17.5.2. Opiates/Opioids
17.5.3. Sleeping
Pills
17.5.4. Stimulants
17.5.5. Others
17.6. Middle
East and Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Addiction Type
17.6.1. Mild
Substance Use Disorders
17.6.2. Chronic
Substance Use Disorders
17.7. Middle
East and Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Providers
17.7.1. Hospitals/Clinics
17.7.2. Rehabilitation
Centers
17.7.3. Urgent
Care Centers
17.7.4. Others
17.8. Middle
East and Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts,
By Country
17.8.1. Saudi
Arabia
17.8.1.1. Saudi
Arabia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
17.8.1.1.1. Detoxification
17.8.1.1.2. Medication
17.8.1.1.2.1. Naltrexone
17.8.1.1.2.2. Acamprosate
17.8.1.1.2.3. Disulfiram
17.8.1.1.2.4. Buprenorphine
17.8.1.1.2.5. Methadone
17.8.1.1.2.6. Others
17.8.1.1.3. Behavioral
Therapies and Counseling
17.8.1.1.3.1. Cognitive-Behavioral
Therapy (CBT)
17.8.1.1.3.2. Motivational
Enhancement Therapy (MET)
17.8.1.1.3.3. Multidimensional
Family Therapy
17.8.1.1.3.4. Dialectic
Behavioural Therapy
17.8.1.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
17.8.1.1.3.6. Therapeutic
Communities
17.8.1.1.3.7. Recovery
Housing
17.8.1.1.3.8. Self-help
Groups
17.8.1.1.3.9. Online
Counseling
17.8.1.1.3.10. Psychotherapy
17.8.1.1.3.11. Mindfulness
17.8.1.1.3.12. Specialty
Therapies
17.8.1.1.3.12.1. Music Therapy
17.8.1.1.3.12.2. Yoga Therapy
17.8.1.1.3.12.3. Animal Assisted Therapy
17.8.1.1.3.12.4. Art Therapy
17.8.1.1.3.12.5. Others
17.8.1.1.3.13. Others
17.8.1.1.4. Substance
Abuse Services
17.8.1.1.4.1. Vocational
Services
17.8.1.1.4.2. Mental
Health Services
17.8.1.1.4.3. Medical
Services
17.8.1.1.4.4. Educational
Services
17.8.1.1.4.5. HIV/AIDS
Services
17.8.1.1.4.6. Legal
Services
17.8.1.1.4.7. Family
Services
17.8.1.1.4.8. Others
17.8.1.1.5. Combination
Treatment
17.8.1.1.6. Others
17.8.1.2. Saudi
Arabia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
17.8.1.2.1. Withdrawal
Symptoms
17.8.1.2.2. Relapse
Prevention
17.8.1.2.3. Co-Occurring
Conditions
17.8.1.2.3.1. Depression
17.8.1.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
17.8.1.2.3.3. Bipolar
Disorder
17.8.1.2.3.4. Schizophrenia
17.8.1.2.3.5. Others
17.8.1.2.4. Others
17.8.1.3. Saudi
Arabia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
17.8.1.3.1. Adolescents
17.8.1.3.2. Young
Adults
17.8.1.3.3. Adults
17.8.1.3.4. Elderly
17.8.1.4. Saudi
Arabia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug
Type
17.8.1.4.1. Illicit
Drugs
17.8.1.4.1.1. Cocaine
17.8.1.4.1.2. Crack
Cocaine
17.8.1.4.1.3. Ecstasy
17.8.1.4.1.4. Marijuana
17.8.1.4.1.5. Hallucinogens
17.8.1.4.1.6. Methamphetamine
17.8.1.4.1.7. Heroin
17.8.1.4.1.8. Others
17.8.1.4.2. Opiates/Opioids
17.8.1.4.3. Sleeping
Pills
17.8.1.4.4. Stimulants
17.8.1.4.5. Others
17.8.1.5. Saudi
Arabia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Addiction Type
17.8.1.5.1. Mild
Substance Use Disorders
17.8.1.5.2. Chronic
Substance Use Disorders
17.8.1.6. Saudi
Arabia Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
17.8.1.6.1. Hospitals/Clinics
17.8.1.6.2. Rehabilitation
Centers
17.8.1.6.3. Urgent
Care Centers
17.8.1.6.4. Others
17.8.2. UAE
17.8.2.1. UAE
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
17.8.2.1.1. Detoxification
17.8.2.1.2. Medication
17.8.2.1.2.1. Naltrexone
17.8.2.1.2.2. Acamprosate
17.8.2.1.2.3. Disulfiram
17.8.2.1.2.4. Buprenorphine
17.8.2.1.2.5. Methadone
17.8.2.1.2.6. Others
17.8.2.1.3. Behavioral
Therapies and Counseling
17.8.2.1.3.1. Cognitive-Behavioral
Therapy (CBT)
17.8.2.1.3.2. Motivational
Enhancement Therapy (MET)
17.8.2.1.3.3. Multidimensional
Family Therapy
17.8.2.1.3.4. Dialectic
Behavioural Therapy
17.8.2.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
17.8.2.1.3.6. Therapeutic
Communities
17.8.2.1.3.7. Recovery
Housing
17.8.2.1.3.8. Self-help
Groups
17.8.2.1.3.9. Online
Counseling
17.8.2.1.3.10. Psychotherapy
17.8.2.1.3.11. Mindfulness
17.8.2.1.3.12. Specialty
Therapies
17.8.2.1.3.12.1. Music Therapy
17.8.2.1.3.12.2. Yoga Therapy
17.8.2.1.3.12.3. Animal Assisted Therapy
17.8.2.1.3.12.4. Art Therapy
17.8.2.1.3.12.5. Others
17.8.2.1.3.13. Others
17.8.2.1.4. Substance
Abuse Services
17.8.2.1.4.1. Vocational
Services
17.8.2.1.4.2. Mental
Health Services
17.8.2.1.4.3. Medical
Services
17.8.2.1.4.4. Educational
Services
17.8.2.1.4.5. HIV/AIDS
Services
17.8.2.1.4.6. Legal
Services
17.8.2.1.4.7. Family
Services
17.8.2.1.4.8. Others
17.8.2.1.5. Combination
Treatment
17.8.2.1.6. Others
17.8.2.2. UAE
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
17.8.2.2.1. Withdrawal
Symptoms
17.8.2.2.2. Relapse
Prevention
17.8.2.2.3. Co-Occurring
Conditions
17.8.2.2.3.1. Depression
17.8.2.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
17.8.2.2.3.3. Bipolar
Disorder
17.8.2.2.3.4. Schizophrenia
17.8.2.2.3.5. Others
17.8.2.2.4. Others
17.8.2.3. UAE
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
17.8.2.3.1. Adolescents
17.8.2.3.2. Young
Adults
17.8.2.3.3. Adults
17.8.2.3.4. Elderly
17.8.2.4. UAE
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
17.8.2.4.1. Illicit
Drugs
17.8.2.4.1.1. Cocaine
17.8.2.4.1.2. Crack
Cocaine
17.8.2.4.1.3. Ecstasy
17.8.2.4.1.4. Marijuana
17.8.2.4.1.5. Hallucinogens
17.8.2.4.1.6. Methamphetamine
17.8.2.4.1.7. Heroin
17.8.2.4.1.8. Others
17.8.2.4.2. Opiates/Opioids
17.8.2.4.3. Sleeping
Pills
17.8.2.4.4. Stimulants
17.8.2.4.5. Others
17.8.2.5. UAE
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
17.8.2.5.1. Mild
Substance Use Disorders
17.8.2.5.2. Chronic
Substance Use Disorders
17.8.2.6. UAE
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
17.8.2.6.1. Hospitals/Clinics
17.8.2.6.2. Rehabilitation
Centers
17.8.2.6.3. Urgent
Care Centers
17.8.2.6.4. Others
17.8.3. Egypt
17.8.3.1. Egypt
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
17.8.3.1.1. Detoxification
17.8.3.1.2. Medication
17.8.3.1.2.1. Naltrexone
17.8.3.1.2.2. Acamprosate
17.8.3.1.2.3. Disulfiram
17.8.3.1.2.4. Buprenorphine
17.8.3.1.2.5. Methadone
17.8.3.1.2.6. Others
17.8.3.1.3. Behavioral
Therapies and Counseling
17.8.3.1.3.1. Cognitive-Behavioral
Therapy (CBT)
17.8.3.1.3.2. Motivational
Enhancement Therapy (MET)
17.8.3.1.3.3. Multidimensional
Family Therapy
17.8.3.1.3.4. Dialectic
Behavioural Therapy
17.8.3.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
17.8.3.1.3.6. Therapeutic
Communities
17.8.3.1.3.7. Recovery
Housing
17.8.3.1.3.8. Self-help
Groups
17.8.3.1.3.9. Online
Counseling
17.8.3.1.3.10. Psychotherapy
17.8.3.1.3.11. Mindfulness
17.8.3.1.3.12. Specialty
Therapies
17.8.3.1.3.12.1. Music Therapy
17.8.3.1.3.12.2. Yoga Therapy
17.8.3.1.3.12.3. Animal Assisted Therapy
17.8.3.1.3.12.4. Art Therapy
17.8.3.1.3.12.5. Others
17.8.3.1.3.13. Others
17.8.3.1.4. Substance
Abuse Services
17.8.3.1.4.1. Vocational
Services
17.8.3.1.4.2. Mental
Health Services
17.8.3.1.4.3. Medical
Services
17.8.3.1.4.4. Educational
Services
17.8.3.1.4.5. HIV/AIDS
Services
17.8.3.1.4.6. Legal
Services
17.8.3.1.4.7. Family
Services
17.8.3.1.4.8. Others
17.8.3.1.5. Combination
Treatment
17.8.3.1.6. Others
17.8.3.2. Egypt
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
17.8.3.2.1. Withdrawal
Symptoms
17.8.3.2.2. Relapse
Prevention
17.8.3.2.3. Co-Occurring
Conditions
17.8.3.2.3.1. Depression
17.8.3.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
17.8.3.2.3.3. Bipolar
Disorder
17.8.3.2.3.4. Schizophrenia
17.8.3.2.3.5. Others
17.8.3.2.4. Others
17.8.3.3. Egypt
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
17.8.3.3.1. Adolescents
17.8.3.3.2. Young
Adults
17.8.3.3.3. Adults
17.8.3.3.4. Elderly
17.8.3.4. Egypt
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
17.8.3.4.1. Illicit
Drugs
17.8.3.4.1.1. Cocaine
17.8.3.4.1.2. Crack
Cocaine
17.8.3.4.1.3. Ecstasy
17.8.3.4.1.4. Marijuana
17.8.3.4.1.5. Hallucinogens
17.8.3.4.1.6. Methamphetamine
17.8.3.4.1.7. Heroin
17.8.3.4.1.8. Others
17.8.3.4.2. Opiates/Opioids
17.8.3.4.3. Sleeping
Pills
17.8.3.4.4. Stimulants
17.8.3.4.5. Others
17.8.3.5. Egypt
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
17.8.3.5.1. Mild
Substance Use Disorders
17.8.3.5.2. Chronic
Substance Use Disorders
17.8.3.6. Egypt
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
17.8.3.6.1. Hospitals/Clinics
17.8.3.6.2. Rehabilitation
Centers
17.8.3.6.3. Urgent
Care Centers
17.8.3.6.4. Others
17.8.4. Kuwait
17.8.4.1. Kuwait
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
17.8.4.1.1. Detoxification
17.8.4.1.2. Medication
17.8.4.1.2.1. Naltrexone
17.8.4.1.2.2. Acamprosate
17.8.4.1.2.3. Disulfiram
17.8.4.1.2.4. Buprenorphine
17.8.4.1.2.5. Methadone
17.8.4.1.2.6. Others
17.8.4.1.3. Behavioral
Therapies and Counseling
17.8.4.1.3.1. Cognitive-Behavioral
Therapy (CBT)
17.8.4.1.3.2. Motivational
Enhancement Therapy (MET)
17.8.4.1.3.3. Multidimensional
Family Therapy
17.8.4.1.3.4. Dialectic
Behavioural Therapy
17.8.4.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
17.8.4.1.3.6. Therapeutic
Communities
17.8.4.1.3.7. Recovery
Housing
17.8.4.1.3.8. Self-help
Groups
17.8.4.1.3.9. Online
Counseling
17.8.4.1.3.10. Psychotherapy
17.8.4.1.3.11. Mindfulness
17.8.4.1.3.12. Specialty
Therapies
17.8.4.1.3.12.1. Music Therapy
17.8.4.1.3.12.2. Yoga Therapy
17.8.4.1.3.12.3. Animal Assisted Therapy
17.8.4.1.3.12.4. Art Therapy
17.8.4.1.3.12.5. Others
17.8.4.1.3.13. Others
17.8.4.1.4. Substance
Abuse Services
17.8.4.1.4.1. Vocational
Services
17.8.4.1.4.2. Mental
Health Services
17.8.4.1.4.3. Medical
Services
17.8.4.1.4.4. Educational
Services
17.8.4.1.4.5. HIV/AIDS
Services
17.8.4.1.4.6. Legal
Services
17.8.4.1.4.7. Family
Services
17.8.4.1.4.8. Others
17.8.4.1.5. Combination
Treatment
17.8.4.1.6. Others
17.8.4.2. Kuwait
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
17.8.4.2.1. Withdrawal
Symptoms
17.8.4.2.2. Relapse
Prevention
17.8.4.2.3. Co-Occurring
Conditions
17.8.4.2.3.1. Depression
17.8.4.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
17.8.4.2.3.3. Bipolar
Disorder
17.8.4.2.3.4. Schizophrenia
17.8.4.2.3.5. Others
17.8.4.2.4. Others
17.8.4.3. Kuwait
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
17.8.4.3.1. Adolescents
17.8.4.3.2. Young
Adults
17.8.4.3.3. Adults
17.8.4.3.4. Elderly
17.8.4.4. Kuwait
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
17.8.4.4.1. Illicit
Drugs
17.8.4.4.1.1. Cocaine
17.8.4.4.1.2. Crack
Cocaine
17.8.4.4.1.3. Ecstasy
17.8.4.4.1.4. Marijuana
17.8.4.4.1.5. Hallucinogens
17.8.4.4.1.6. Methamphetamine
17.8.4.4.1.7. Heroin
17.8.4.4.1.8. Others
17.8.4.4.2. Opiates/Opioids
17.8.4.4.3. Sleeping
Pills
17.8.4.4.4. Stimulants
17.8.4.4.5. Others
17.8.4.5. Kuwait
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
17.8.4.5.1. Mild
Substance Use Disorders
17.8.4.5.2. Chronic
Substance Use Disorders
17.8.4.6. Kuwait
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
17.8.4.6.1. Hospitals/Clinics
17.8.4.6.2. Rehabilitation
Centers
17.8.4.6.3. Urgent
Care Centers
17.8.4.6.4. Others
17.8.5. South
Africa
17.8.5.1. South
Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
17.8.5.1.1. Detoxification
17.8.5.1.2. Medication
17.8.5.1.2.1. Naltrexone
17.8.5.1.2.2. Acamprosate
17.8.5.1.2.3. Disulfiram
17.8.5.1.2.4. Buprenorphine
17.8.5.1.2.5. Methadone
17.8.5.1.2.6. Others
17.8.5.1.3. Behavioral
Therapies and Counseling
17.8.5.1.3.1. Cognitive-Behavioral
Therapy (CBT)
17.8.5.1.3.2. Motivational
Enhancement Therapy (MET)
17.8.5.1.3.3. Multidimensional
Family Therapy
17.8.5.1.3.4. Dialectic
Behavioural Therapy
17.8.5.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
17.8.5.1.3.6. Therapeutic
Communities
17.8.5.1.3.7. Recovery
Housing
17.8.5.1.3.8. Self-help
Groups
17.8.5.1.3.9. Online
Counseling
17.8.5.1.3.10. Psychotherapy
17.8.5.1.3.11. Mindfulness
17.8.5.1.3.12. Specialty
Therapies
17.8.5.1.3.12.1. Music Therapy
17.8.5.1.3.12.2. Yoga Therapy
17.8.5.1.3.12.3. Animal Assisted Therapy
17.8.5.1.3.12.4. Art Therapy
17.8.5.1.3.12.5. Others
17.8.5.1.3.13. Others
17.8.5.1.4. Substance
Abuse Services
17.8.5.1.4.1. Vocational
Services
17.8.5.1.4.2. Mental
Health Services
17.8.5.1.4.3. Medical
Services
17.8.5.1.4.4. Educational
Services
17.8.5.1.4.5. HIV/AIDS
Services
17.8.5.1.4.6. Legal
Services
17.8.5.1.4.7. Family
Services
17.8.5.1.4.8. Others
17.8.5.1.5. Combination
Treatment
17.8.5.1.6. Others
17.8.5.2. South
Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
17.8.5.2.1. Withdrawal
Symptoms
17.8.5.2.2. Relapse
Prevention
17.8.5.2.3. Co-Occurring
Conditions
17.8.5.2.3.1. Depression
17.8.5.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
17.8.5.2.3.3. Bipolar
Disorder
17.8.5.2.3.4. Schizophrenia
17.8.5.2.3.5. Others
17.8.5.2.4. Others
17.8.5.3. South
Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
17.8.5.3.1. Adolescents
17.8.5.3.2. Young
Adults
17.8.5.3.3. Adults
17.8.5.3.4. Elderly
17.8.5.4. South
Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug
Type
17.8.5.4.1. Illicit
Drugs
17.8.5.4.1.1. Cocaine
17.8.5.4.1.2. Crack
Cocaine
17.8.5.4.1.3. Ecstasy
17.8.5.4.1.4. Marijuana
17.8.5.4.1.5. Hallucinogens
17.8.5.4.1.6. Methamphetamine
17.8.5.4.1.7. Heroin
17.8.5.4.1.8. Others
17.8.5.4.2. Opiates/Opioids
17.8.5.4.3. Sleeping
Pills
17.8.5.4.4. Stimulants
17.8.5.4.5. Others
17.8.5.5. South
Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Addiction Type
17.8.5.5.1. Mild
Substance Use Disorders
17.8.5.5.2. Chronic
Substance Use Disorders
17.8.5.6. South
Africa Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
17.8.5.6.1. Hospitals/Clinics
17.8.5.6.2. Rehabilitation
Centers
17.8.5.6.3. Urgent
Care Centers
17.8.5.6.4. Others
17.8.6. Rest of
Middle East & Africa
17.8.6.1. Rest
of Middle East & Africa Drug Addiction Treatment Market Revenue (US$ Mn)
and Forecasts, By Treatment Type
17.8.6.1.1. Detoxification
17.8.6.1.2. Medication
17.8.6.1.2.1. Naltrexone
17.8.6.1.2.2. Acamprosate
17.8.6.1.2.3. Disulfiram
17.8.6.1.2.4. Buprenorphine
17.8.6.1.2.5. Methadone
17.8.6.1.2.6. Others
17.8.6.1.3. Behavioral
Therapies and Counseling
17.8.6.1.3.1. Cognitive-Behavioral
Therapy (CBT)
17.8.6.1.3.2. Motivational
Enhancement Therapy (MET)
17.8.6.1.3.3. Multidimensional
Family Therapy
17.8.6.1.3.4. Dialectic
Behavioural Therapy
17.8.6.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
17.8.6.1.3.6. Therapeutic
Communities
17.8.6.1.3.7. Recovery
Housing
17.8.6.1.3.8. Self-help
Groups
17.8.6.1.3.9. Online
Counseling
17.8.6.1.3.10. Psychotherapy
17.8.6.1.3.11. Mindfulness
17.8.6.1.3.12. Specialty
Therapies
17.8.6.1.3.12.1. Music Therapy
17.8.6.1.3.12.2. Yoga Therapy
17.8.6.1.3.12.3. Animal Assisted Therapy
17.8.6.1.3.12.4. Art Therapy
17.8.6.1.3.12.5. Others
17.8.6.1.3.13. Others
17.8.6.1.4. Substance
Abuse Services
17.8.6.1.4.1. Vocational
Services
17.8.6.1.4.2. Mental
Health Services
17.8.6.1.4.3. Medical
Services
17.8.6.1.4.4. Educational
Services
17.8.6.1.4.5. HIV/AIDS
Services
17.8.6.1.4.6. Legal
Services
17.8.6.1.4.7. Family
Services
17.8.6.1.4.8. Others
17.8.6.1.5. Combination
Treatment
17.8.6.1.6. Others
17.8.6.2. Rest
of Middle East & Africa Drug Addiction Treatment Market Revenue (US$ Mn)
and Forecasts, By Application
17.8.6.2.1. Withdrawal
Symptoms
17.8.6.2.2. Relapse
Prevention
17.8.6.2.3. Co-Occurring
Conditions
17.8.6.2.3.1. Depression
17.8.6.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
17.8.6.2.3.3. Bipolar
Disorder
17.8.6.2.3.4. Schizophrenia
17.8.6.2.3.5. Others
17.8.6.2.4. Others
17.8.6.3. Rest
of Middle East & Africa Drug Addiction Treatment Market Revenue (US$ Mn)
and Forecasts, By Age Group
17.8.6.3.1. Adolescents
17.8.6.3.2. Young
Adults
17.8.6.3.3. Adults
17.8.6.3.4. Elderly
17.8.6.4. Rest
of Middle East & Africa Drug Addiction Treatment Market Revenue (US$ Mn)
and Forecasts, By Drug Type
17.8.6.4.1. Illicit
Drugs
17.8.6.4.1.1. Cocaine
17.8.6.4.1.2. Crack
Cocaine
17.8.6.4.1.3. Ecstasy
17.8.6.4.1.4. Marijuana
17.8.6.4.1.5. Hallucinogens
17.8.6.4.1.6. Methamphetamine
17.8.6.4.1.7. Heroin
17.8.6.4.1.8. Others
17.8.6.4.2. Opiates/Opioids
17.8.6.4.3. Sleeping
Pills
17.8.6.4.4. Stimulants
17.8.6.4.5. Others
17.8.6.5. Rest
of Middle East & Africa Drug Addiction Treatment Market Revenue (US$ Mn)
and Forecasts, By Addiction Type
17.8.6.5.1. Mild
Substance Use Disorders
17.8.6.5.2. Chronic
Substance Use Disorders
17.8.6.6. Rest
of Middle East & Africa Drug Addiction Treatment Market Revenue (US$ Mn)
and Forecasts, By Providers
17.8.6.6.1. Hospitals/Clinics
17.8.6.6.2. Rehabilitation
Centers
17.8.6.6.3. Urgent
Care Centers
17.8.6.6.4. Others
17.9. Key
Segment for Channeling Investments
17.9.1. By
Country
17.9.2. By
Treatment Type
17.9.3. By
Application
17.9.4. By Age
Group
17.9.5. By Drug
Type
17.9.6. By
Addiction Type
17.9.7. By
Providers
18. Latin
America Drug Addiction Treatment Market Analysis and Forecasts, 2019 - 2027
18.1. Overview
18.1.1. Latin
America Drug Addiction Treatment Market Revenue (US$ Mn)
18.2. Latin
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Treatment Type
18.2.1. Detoxification
18.2.2. Medication
18.2.2.1. Naltrexone
18.2.2.2. Acamprosate
18.2.2.3. Disulfiram
18.2.2.4. Buprenorphine
18.2.2.5. Methadone
18.2.2.6. Others
18.2.3. Behavioral
Therapies and Counseling
18.2.3.1. Cognitive-Behavioral
Therapy (CBT)
18.2.3.2. Motivational
Enhancement Therapy (MET)
18.2.3.3. Multidimensional
Family Therapy
18.2.3.4. Dialectic
Behavioural Therapy
18.2.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
18.2.3.6. Therapeutic
Communities
18.2.3.7. Recovery
Housing
18.2.3.8. Self-help
Groups
18.2.3.9. Online
Counseling
18.2.3.10. Psychotherapy
18.2.3.11. Mindfulness
18.2.3.12. Specialty
Therapies
18.2.3.12.1. Music
Therapy
18.2.3.12.2. Yoga
Therapy
18.2.3.12.3. Animal
Assisted Therapy
18.2.3.12.4. Art
Therapy
18.2.3.12.5. Others
18.2.3.13. Others
18.2.4. Substance
Abuse Services
18.2.4.1. Vocational
Services
18.2.4.2. Mental
Health Services
18.2.4.3. Medical
Services
18.2.4.4. Educational
Services
18.2.4.5. HIV/AIDS
Services
18.2.4.6. Legal
Services
18.2.4.7. Family
Services
18.2.4.8. Others
18.2.5. Combination
Treatment
18.2.6. Others
18.3. Latin
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Application
18.3.1. Withdrawal
Symptoms
18.3.2. Relapse
Prevention
18.3.3. Co-Occurring
Conditions
18.3.3.1. Depression
18.3.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
18.3.3.3. Bipolar
Disorder
18.3.3.4. Schizophrenia
18.3.3.5. Others
18.3.4. Others
18.4. Latin
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age
Group
18.4.1. Adolescents
18.4.2. Young
Adults
18.4.3. Adults
18.4.4. Elderly
18.5. Latin
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug
Type
18.5.1. Illicit
Drugs
18.5.1.1. Cocaine
18.5.1.2. Crack
Cocaine
18.5.1.3. Ecstasy
18.5.1.4. Marijuana
18.5.1.5. Hallucinogens
18.5.1.6. Methamphetamine
18.5.1.7. Heroin
18.5.1.8. Others
18.5.2. Opiates/Opioids
18.5.3. Sleeping
Pills
18.5.4. Stimulants
18.5.5. Others
18.6. Latin
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Addiction Type
18.6.1. Mild
Substance Use Disorders
18.6.2. Chronic
Substance Use Disorders
18.7. Latin
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Providers
18.7.1. Hospitals/Clinics
18.7.2. Rehabilitation
Centers
18.7.3. Urgent
Care Centers
18.7.4. Others
18.8. Latin
America Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By
Country
18.8.1. Brazil
18.8.1.1. Brazil
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
18.8.1.1.1. Detoxification
18.8.1.1.2. Medication
18.8.1.1.2.1. Naltrexone
18.8.1.1.2.2. Acamprosate
18.8.1.1.2.3. Disulfiram
18.8.1.1.2.4. Buprenorphine
18.8.1.1.2.5. Methadone
18.8.1.1.2.6. Others
18.8.1.1.3. Behavioral
Therapies and Counseling
18.8.1.1.3.1. Cognitive-Behavioral
Therapy (CBT)
18.8.1.1.3.2. Motivational
Enhancement Therapy (MET)
18.8.1.1.3.3. Multidimensional
Family Therapy
18.8.1.1.3.4. Dialectic
Behavioural Therapy
18.8.1.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
18.8.1.1.3.6. Therapeutic
Communities
18.8.1.1.3.7. Recovery
Housing
18.8.1.1.3.8. Self-help
Groups
18.8.1.1.3.9. Online
Counseling
18.8.1.1.3.10. Psychotherapy
18.8.1.1.3.11. Mindfulness
18.8.1.1.3.12. Specialty
Therapies
18.8.1.1.3.12.1. Music Therapy
18.8.1.1.3.12.2. Yoga Therapy
18.8.1.1.3.12.3. Animal Assisted Therapy
18.8.1.1.3.12.4. Art Therapy
18.8.1.1.3.12.5. Others
18.8.1.1.3.13. Others
18.8.1.1.4. Substance
Abuse Services
18.8.1.1.4.1. Vocational
Services
18.8.1.1.4.2. Mental
Health Services
18.8.1.1.4.3. Medical
Services
18.8.1.1.4.4. Educational
Services
18.8.1.1.4.5. HIV/AIDS
Services
18.8.1.1.4.6. Legal
Services
18.8.1.1.4.7. Family
Services
18.8.1.1.4.8. Others
18.8.1.1.5. Combination
Treatment
18.8.1.1.6. Others
18.8.1.2. Brazil
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
18.8.1.2.1. Withdrawal
Symptoms
18.8.1.2.2. Relapse
Prevention
18.8.1.2.3. Co-Occurring
Conditions
18.8.1.2.3.1. Depression
18.8.1.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
18.8.1.2.3.3. Bipolar
Disorder
18.8.1.2.3.4. Schizophrenia
18.8.1.2.3.5. Others
18.8.1.2.4. Others
18.8.1.3. Brazil
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
18.8.1.3.1. Adolescents
18.8.1.3.2. Young
Adults
18.8.1.3.3. Adults
18.8.1.3.4. Elderly
18.8.1.4. Brazil
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
18.8.1.4.1. Illicit
Drugs
18.8.1.4.1.1. Cocaine
18.8.1.4.1.2. Crack
Cocaine
18.8.1.4.1.3. Ecstasy
18.8.1.4.1.4. Marijuana
18.8.1.4.1.5. Hallucinogens
18.8.1.4.1.6. Methamphetamine
18.8.1.4.1.7. Heroin
18.8.1.4.1.8. Others
18.8.1.4.2. Opiates/Opioids
18.8.1.4.3. Sleeping
Pills
18.8.1.4.4. Stimulants
18.8.1.4.5. Others
18.8.1.5. Brazil
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
18.8.1.5.1. Mild
Substance Use Disorders
18.8.1.5.2. Chronic
Substance Use Disorders
18.8.1.6. Brazil
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
18.8.1.6.1. Hospitals/Clinics
18.8.1.6.2. Rehabilitation
Centers
18.8.1.6.3. Urgent
Care Centers
18.8.1.6.4. Others
18.8.2. Argentina
18.8.2.1. Argentina
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment
Type
18.8.2.1.1. Detoxification
18.8.2.1.2. Medication
18.8.2.1.2.1. Naltrexone
18.8.2.1.2.2. Acamprosate
18.8.2.1.2.3. Disulfiram
18.8.2.1.2.4. Buprenorphine
18.8.2.1.2.5. Methadone
18.8.2.1.2.6. Others
18.8.2.1.3. Behavioral
Therapies and Counseling
18.8.2.1.3.1. Cognitive-Behavioral
Therapy (CBT)
18.8.2.1.3.2. Motivational
Enhancement Therapy (MET)
18.8.2.1.3.3. Multidimensional
Family Therapy
18.8.2.1.3.4. Dialectic
Behavioural Therapy
18.8.2.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
18.8.2.1.3.6. Therapeutic
Communities
18.8.2.1.3.7. Recovery
Housing
18.8.2.1.3.8. Self-help
Groups
18.8.2.1.3.9. Online
Counseling
18.8.2.1.3.10. Psychotherapy
18.8.2.1.3.11. Mindfulness
18.8.2.1.3.12. Specialty
Therapies
18.8.2.1.3.12.1. Music Therapy
18.8.2.1.3.12.2. Yoga Therapy
18.8.2.1.3.12.3. Animal Assisted Therapy
18.8.2.1.3.12.4. Art Therapy
18.8.2.1.3.12.5. Others
18.8.2.1.3.13. Others
18.8.2.1.4. Substance
Abuse Services
18.8.2.1.4.1. Vocational
Services
18.8.2.1.4.2. Mental
Health Services
18.8.2.1.4.3. Medical
Services
18.8.2.1.4.4. Educational
Services
18.8.2.1.4.5. HIV/AIDS
Services
18.8.2.1.4.6. Legal
Services
18.8.2.1.4.7. Family
Services
18.8.2.1.4.8. Others
18.8.2.1.5. Combination
Treatment
18.8.2.1.6. Others
18.8.2.2. Argentina
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Application
18.8.2.2.1. Withdrawal
Symptoms
18.8.2.2.2. Relapse
Prevention
18.8.2.2.3. Co-Occurring
Conditions
18.8.2.2.3.1. Depression
18.8.2.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
18.8.2.2.3.3. Bipolar
Disorder
18.8.2.2.3.4. Schizophrenia
18.8.2.2.3.5. Others
18.8.2.2.4. Others
18.8.2.3. Argentina
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Age Group
18.8.2.3.1. Adolescents
18.8.2.3.2. Young
Adults
18.8.2.3.3. Adults
18.8.2.3.4. Elderly
18.8.2.4. Argentina
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Drug Type
18.8.2.4.1. Illicit
Drugs
18.8.2.4.1.1. Cocaine
18.8.2.4.1.2. Crack
Cocaine
18.8.2.4.1.3. Ecstasy
18.8.2.4.1.4. Marijuana
18.8.2.4.1.5. Hallucinogens
18.8.2.4.1.6. Methamphetamine
18.8.2.4.1.7. Heroin
18.8.2.4.1.8. Others
18.8.2.4.2. Opiates/Opioids
18.8.2.4.3. Sleeping
Pills
18.8.2.4.4. Stimulants
18.8.2.4.5. Others
18.8.2.5. Argentina
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Addiction
Type
18.8.2.5.1. Mild
Substance Use Disorders
18.8.2.5.2. Chronic
Substance Use Disorders
18.8.2.6. Argentina
Drug Addiction Treatment Market Revenue (US$ Mn) and Forecasts, By Providers
18.8.2.6.1. Hospitals/Clinics
18.8.2.6.2. Rehabilitation
Centers
18.8.2.6.3. Urgent
Care Centers
18.8.2.6.4. Others
18.8.3. Rest of
Latin America
18.8.3.1. Rest
of Latin America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Treatment Type
18.8.3.1.1. Detoxification
18.8.3.1.2. Medication
18.8.3.1.2.1. Naltrexone
18.8.3.1.2.2. Acamprosate
18.8.3.1.2.3. Disulfiram
18.8.3.1.2.4. Buprenorphine
18.8.3.1.2.5. Methadone
18.8.3.1.2.6. Others
18.8.3.1.3. Behavioral
Therapies and Counseling
18.8.3.1.3.1. Cognitive-Behavioral
Therapy (CBT)
18.8.3.1.3.2. Motivational
Enhancement Therapy (MET)
18.8.3.1.3.3. Multidimensional
Family Therapy
18.8.3.1.3.4. Dialectic
Behavioural Therapy
18.8.3.1.3.5. Rational
Emotive Behavior Therapy (REBT) Therapy
18.8.3.1.3.6. Therapeutic
Communities
18.8.3.1.3.7. Recovery
Housing
18.8.3.1.3.8. Self-help
Groups
18.8.3.1.3.9. Online
Counseling
18.8.3.1.3.10. Psychotherapy
18.8.3.1.3.11. Mindfulness
18.8.3.1.3.12. Specialty
Therapies
18.8.3.1.3.12.1. Music Therapy
18.8.3.1.3.12.2. Yoga Therapy
18.8.3.1.3.12.3. Animal Assisted Therapy
18.8.3.1.3.12.4. Art Therapy
18.8.3.1.3.12.5. Others
18.8.3.1.3.13. Others
18.8.3.1.4. Substance
Abuse Services
18.8.3.1.4.1. Vocational
Services
18.8.3.1.4.2. Mental
Health Services
18.8.3.1.4.3. Medical
Services
18.8.3.1.4.4. Educational
Services
18.8.3.1.4.5. HIV/AIDS
Services
18.8.3.1.4.6. Legal
Services
18.8.3.1.4.7. Family
Services
18.8.3.1.4.8. Others
18.8.3.1.5. Combination
Treatment
18.8.3.1.6. Others
18.8.3.2. Rest
of Latin America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Application
18.8.3.2.1. Withdrawal
Symptoms
18.8.3.2.2. Relapse
Prevention
18.8.3.2.3. Co-Occurring
Conditions
18.8.3.2.3.1. Depression
18.8.3.2.3.2. Anxiety
Disorders (Including Post-Traumatic Stress Disorder)
18.8.3.2.3.3. Bipolar
Disorder
18.8.3.2.3.4. Schizophrenia
18.8.3.2.3.5. Others
18.8.3.2.4. Others
18.8.3.3. Rest
of Latin America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Age Group
18.8.3.3.1. Adolescents
18.8.3.3.2. Young
Adults
18.8.3.3.3. Adults
18.8.3.3.4. Elderly
18.8.3.4. Rest
of Latin America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Drug Type
18.8.3.4.1. Illicit
Drugs
18.8.3.4.1.1. Cocaine
18.8.3.4.1.2. Crack
Cocaine
18.8.3.4.1.3. Ecstasy
18.8.3.4.1.4. Marijuana
18.8.3.4.1.5. Hallucinogens
18.8.3.4.1.6. Methamphetamine
18.8.3.4.1.7. Heroin
18.8.3.4.1.8. Others
18.8.3.4.2. Opiates/Opioids
18.8.3.4.3. Sleeping
Pills
18.8.3.4.4. Stimulants
18.8.3.4.5. Others
18.8.3.5. Rest
of Latin America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Addiction Type
18.8.3.5.1. Mild
Substance Use Disorders
18.8.3.5.2. Chronic
Substance Use Disorders
18.8.3.6. Rest
of Latin America Drug Addiction Treatment Market Revenue (US$ Mn) and
Forecasts, By Providers
18.8.3.6.1. Hospitals/Clinics
18.8.3.6.2. Rehabilitation
Centers
18.8.3.6.3. Urgent
Care Centers
18.8.3.6.4. Others
18.9. Key
Segment for Channeling Investments
18.9.1. By
Country
18.9.2. By
Treatment Type
18.9.3. By
Application
18.9.4. By Age
Group
18.9.5. By Drug
Type
18.9.6. By
Addiction Type
18.9.7. By
Providers
19. Competitive
Benchmarking
19.1. Market
Share Analysis, 2018
19.2. Global
Presence and Growth Strategies
19.2.1. Mergers
and Acquisitions
19.2.2. Product
Launches
19.2.3. Investments
Trends
19.2.4. R&D
Initiatives
20. Player
Profiles
20.1. Addiction
Friend
20.1.1. Company
Details
20.1.2. Company
Overview
20.1.3. Product
Offerings
20.1.4. Key
Developments
20.1.5. Financial
Analysis
20.1.6. SWOT
Analysis
20.1.7. Business
Strategies
20.2. AddictionCenter.com
20.2.1. Company
Details
20.2.2. Company
Overview
20.2.3. Product
Offerings
20.2.4. Key
Developments
20.2.5. Financial
Analysis
20.2.6. SWOT
Analysis
20.2.7. Business
Strategies
20.3. Advanced
Recovery Systems
20.3.1. Company
Details
20.3.2. Company
Overview
20.3.3. Product
Offerings
20.3.4. Key
Developments
20.3.5. Financial
Analysis
20.3.6. SWOT
Analysis
20.3.7. Business
Strategies
20.4. Alkermes
20.4.1. Company
Details
20.4.2. Company
Overview
20.4.3. Product
Offerings
20.4.4. Key
Developments
20.4.5. Financial
Analysis
20.4.6. SWOT
Analysis
20.4.7. Business
Strategies
20.5. American
Addiction Centers, Inc
20.5.1. Company
Details
20.5.2. Company
Overview
20.5.3. Product
Offerings
20.5.4. Key
Developments
20.5.5. Financial
Analysis
20.5.6. SWOT
Analysis
20.5.7. Business
Strategies
20.6. Asia
Health Co., Ltd
20.6.1. Company
Details
20.6.2. Company
Overview
20.6.3. Product
Offerings
20.6.4. Key
Developments
20.6.5. Financial
Analysis
20.6.6. SWOT
Analysis
20.6.7. Business
Strategies
20.7. BioCorRx,
Inc.
20.7.1. Company
Details
20.7.2. Company
Overview
20.7.3. Product
Offerings
20.7.4. Key
Developments
20.7.5. Financial
Analysis
20.7.6. SWOT
Analysis
20.7.7. Business
Strategies
20.8. Castle
Craig Hospital
20.8.1. Company
Details
20.8.2. Company
Overview
20.8.3. Product
Offerings
20.8.4. Key
Developments
20.8.5. Financial
Analysis
20.8.6. SWOT
Analysis
20.8.7. Business
Strategies
20.9. Cedars at
Cobble Hill
20.9.1. Company
Details
20.9.2. Company
Overview
20.9.3. Product
Offerings
20.9.4. Key
Developments
20.9.5. Financial
Analysis
20.9.6. SWOT
Analysis
20.9.7. Business
Strategies
20.10. Detox of
South Florida Inc
20.10.1. Company
Details
20.10.2. Company
Overview
20.10.3. Product
Offerings
20.10.4. Key Developments
20.10.5. Financial
Analysis
20.10.6. SWOT
Analysis
20.10.7. Business
Strategies
20.11. DyAnsys
Inc
20.11.1. Company
Details
20.11.2. Company
Overview
20.11.3. Product
Offerings
20.11.4. Key
Developments
20.11.5. Financial
Analysis
20.11.6. SWOT
Analysis
20.11.7. Business
Strategies
20.12. Foundations
Wellness Center
20.12.1. Company
Details
20.12.2. Company
Overview
20.12.3. Product
Offerings
20.12.4. Key
Developments
20.12.5. Financial
Analysis
20.12.6. SWOT
Analysis
20.12.7. Business
Strategies
20.13. Help 4
Addiction
20.13.1. Company
Details
20.13.2. Company
Overview
20.13.3. Product
Offerings
20.13.4. Key
Developments
20.13.5. Financial
Analysis
20.13.6. SWOT
Analysis
20.13.7. Business
Strategies
20.14. Hope
Recovery Services Limited
20.14.1. Company
Details
20.14.2. Company
Overview
20.14.3. Product
Offerings
20.14.4. Key
Developments
20.14.5. Financial
Analysis
20.14.6. SWOT
Analysis
20.14.7. Business
Strategies
20.15. Indivior
PLC
20.15.1. Company
Details
20.15.2. Company
Overview
20.15.3. Product
Offerings
20.15.4. Key
Developments
20.15.5. Financial
Analysis
20.15.6. SWOT
Analysis
20.15.7. Business
Strategies
20.16. Novartis
AG
20.16.1. Company
Details
20.16.2. Company
Overview
20.16.3. Product
Offerings
20.16.4. Key
Developments
20.16.5. Financial
Analysis
20.16.6. SWOT
Analysis
20.16.7. Business
Strategies
20.17. Paracelsus
Medical AG
20.17.1. Company
Details
20.17.2. Company
Overview
20.17.3. Product
Offerings
20.17.4. Key
Developments
20.17.5. Financial
Analysis
20.17.6. SWOT Analysis
20.17.7. Business
Strategies
20.18. Phoenix
Programmes
20.18.1. Company
Details
20.18.2. Company
Overview
20.18.3. Product
Offerings
20.18.4. Key
Developments
20.18.5. Financial
Analysis
20.18.6. SWOT
Analysis
20.18.7. Business
Strategies
20.19. Pinnacle
Treatment Centers
20.19.1. Company
Details
20.19.2. Company
Overview
20.19.3. Product
Offerings
20.19.4. Key Developments
20.19.5. Financial
Analysis
20.19.6. SWOT
Analysis
20.19.7. Business
Strategies
20.20. Step 1
Recovery Centre
20.20.1. Company
Details
20.20.2. Company
Overview
20.20.3. Product
Offerings
20.20.4. Key
Developments
20.20.5. Financial
Analysis
20.20.6. SWOT
Analysis
20.20.7. Business
Strategies
20.21. Summit
BHC
20.21.1. Company
Details
20.21.2. Company
Overview
20.21.3. Product
Offerings
20.21.4. Key
Developments
20.21.5. Financial
Analysis
20.21.6. SWOT
Analysis
20.21.7. Business
Strategies
20.22. The
Augustine Recovery Center
20.22.1. Company
Details
20.22.2. Company
Overview
20.22.3. Product
Offerings
20.22.4. Key
Developments
20.22.5. Financial
Analysis
20.22.6. SWOT
Analysis
20.22.7. Business
Strategies
20.23. Touchstone
Ranch Recovery Center
20.23.1. Company
Details
20.23.2. Company
Overview
20.23.3. Product
Offerings
20.23.4. Key
Developments
20.23.5. Financial
Analysis
20.23.6. SWOT
Analysis
20.23.7. Business Strategies
20.24. Other
Industry Participants
21. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
